Lewis System and Antigens Lex and Ley

  • Helmut Schenkel-Brunner


The identification of the Lea character is generally attributed to Mourant in 1946 [264], although Ueyama and Furuhata had described it as the T-antigen’ in 1939 (see Race and Sänger [302]). Since that time further characters of the blood group Lewis system have been defined — Le{b} [5], Le c [125], Le d [299], and the embryonal Lewis antigen, Le ab (originally termed Le x) [7](1).


Blood Group Human Milk Blood Group Antigen Lewis Antigen Human Blood Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abe, K., Mckibbin, J. M. & Hakomori, S. I. (1983): The monoclonal antibody directed to difucosylated type 2 chain (Fucα1→2Galβ1→4[Fucα1→3]GlcNAc; Y determinant). J. Biol. Chem. 258, 11793–11797.PubMedGoogle Scholar
  2. 2.
    Andersen, J. (1958): Modifying influence of the secretor gene on the development of the ABH substance. A contribution to the conception of the Lewis group system. Vox Sang. 3, 251–261.PubMedCrossRefGoogle Scholar
  3. 3.
    Andersen, J. (1960): Serological studies on two Lewis sera. Ada Pathol. Microbiol. Scand. 48, 374–384.CrossRefGoogle Scholar
  4. 4.
    Ando, B. & Ibayashi, H. (1986): Identification of anti-Lea by platelet complement fixation. Vox Sang. 50, 169–173.PubMedCrossRefGoogle Scholar
  5. 5.
    Andresen, P. H. (1948): The blood group system L. A new blood group L in2. A case of epistasy within the blood groups. Ada Pathol. Microbiol. Scand. 25, 728-731.Google Scholar
  6. 6.
    Andresen, P. H. (1972): Demonstration of Le” substance in the saliva of ABH non-secretors. Vox Sang. 23, 262–269.CrossRefGoogle Scholar
  7. 7.
    Andresen, P. H. & Jordal, K. (1949): An incomplete agglutinin related to the L-(Lewis) system. Ada Pathol. Microbiol. Scand. 26, 636–638.CrossRefGoogle Scholar
  8. 8.
    Angstrom, J., Falk, K. E., Karlsson, K. A. & Larson, G. (1982): Chemical fingerprinting of glycosphingolipids in meconium of a human blood group O Le(a-b+) secretor. Biochim. Biophys. Ada 710, 428–436.CrossRefGoogle Scholar
  9. 9.
    Ångström, J., Falk, P., Hansson, G. J., Holgersson, J., Karlsson, H., Karlsson, K. A., Stromberg, N. & Thurin, J. (1987): The mono-and difucosyl blood group B glycosphingolipids of rat large intestine differ in type of core saccharide. Biochim. Biophys. Acta 926, 79–86.PubMedCrossRefGoogle Scholar
  10. 10.
    Appelmelk, B. J., Simoons-Smit, I., Negrini, R., Moran, A. P., Aspinall, G. O., Forte, J. G., De Vries, T., Quan, H., Verboom, T., Maaskant, J. J., Ghiara, P., Kuipers, E. J., Bloemena, E., Tadema, T. M., Townsend, R. R., Tyagarajan, K., Crothers, J. M., Monteiro, M. A., Savio, A. & De Graaff, J. (1996): Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect. Immun. 64, 2031–2040.PubMedGoogle Scholar
  11. 11.
    Arcilla, M. B. & Sturgeon, P. (1972): Lewis and ABH substances in amniotic fluid obtained by amniocentesis. Pediatr. Res. 6, 853–858.PubMedCrossRefGoogle Scholar
  12. 12.
    Arcilla, M. B. & Sturgeon, P. (1973): Studies on the secretion of blood group substances. II. Observations on the red cell phenotype Le(a-b-x-). Vox Sang. 25, 72–87.PubMedCrossRefGoogle Scholar
  13. 13.
    Arcilla, M. B. & Sturgeon, P. (1974): Lex, the spurned antigen of the Lewis blood group system. Vox Sang. 26, 425–438.PubMedCrossRefGoogle Scholar
  14. 14.
    Aspinall, G. O. & Monteiro, M. A. (1996): Lipopolysaccharides of Helicobacter pylori strains P466 and MO19: structures of the O antigen and core oligosaccharide regions. Biochemistry 35, 2498–2504.PubMedCrossRefGoogle Scholar
  15. 15.
    Aspinall, G. O., Monteiro, M.A., Pang, H., Walsh, E.J. & Moran, A.P. (1996): Lipopolysaccharide of the Helicobacter pylori type strain NCTC 11637 (ATCC 43504): structure of the O antigen chain and core oligosaccharide regions. Biochemistry 35, 2489–2497.PubMedCrossRefGoogle Scholar
  16. 16.
    Atkinson, B. F., Ernst, C. S., Herlyn, M., Steplewski, Z., Sears, H. F. & Koprowski, H. (1982): Gastrointestinal cancer-associated antigen in immunoperoxidase assay. Cancer Res. 42, 4820–4823.PubMedGoogle Scholar
  17. 17.
    Aubuchon, J. P., Davey, R. J., Anderson, H. J., Patel, S., Stavely, L M., Schoeppner, S. L & Zafiropulos, D}. (1986): Specificity and clinical significance of anti-Lex Transfusion 26, 302–303.PubMedCrossRefGoogle Scholar
  18. 18.
    Baeckström, D., Hansson, G. C., Nilsson, O., Johansson, C., Gendler, S. J. & Lindholm, L. (1991): Purification and characterization of a membrane-bound and a secreted mucin-type glycoprotein carrying the carcinoma-associated sialyl-Lea epitope on distinct core proteins. J. Biol. Chem. 266, 21537–21547.PubMedGoogle Scholar
  19. 19.
    Baeckström, D., Karlsson, N. & Hansson, G. C. (1994): Purification and characterization of sialyl-Lea-carrying mucins of human bile; evidence for the presence of MUC1 and MUC3 apoproteins. J. Biol. Chem. 269, 14430–14437.PubMedGoogle Scholar
  20. 20.
    Baer, H., Naylor, I., Gibbel, N. & Rosenfield, R. E. (1959): The production of precipitating antibody in chickens to a substance present in the fluids of non-secretors of blood groups A, B, and O. J. Immunol. 82, 183–189.PubMedGoogle Scholar
  21. 21.
    Ball, G. E., O’neill, R. A., Schultz, J. E., Lowe, J. B., Weston, B. W., Nagy, J. O., Brown, E. G., Hobbs, C. J. & Bednarski, M. D. (1992): Synthesis and structural analysis using 2-D NMR of sialyl Lewis-X (SLex) and Lewis-X (Lex) oligosaccharides — ligands related to E-selectin (ELAM-1) binding. J. Amer. Chem. Soc. 114, 5449–5451.CrossRefGoogle Scholar
  22. 22.
    Ball, S. P., Tongue, N., Gibaud, A., Le Pendu, J., Mollicone, R., Gérard, G. & Oriol, R. (1991): The human chromosome 19 linkage group FUT1 (H), FUT2 (SE), LE, LU, PEPD, C3, APOC2, D19S7, and D19S9. Ann. Hum. Genet. 55, 225–233.PubMedCrossRefGoogle Scholar
  23. 23.
    Bauer, C. H., Reutter, W. G., Erhart, K. P., Kottgen, E. & Gerok, W. (1978): Decrease of human serum fucosyltransferase as an indicator of successful tumor therapy. Science 201, 1232–1233.PubMedCrossRefGoogle Scholar
  24. 24.
    Bechtel, B., Wand, A. J., Wroblewski, K., Koprowski, H. & Thurin, J. (1990): Conformational analysis of the tumor-associated carbohydrate antigen 19-9 and its Lea blood group antigen component as related to the specificity of monoclonal antibody CO19-9. J. Biol. Chem. 265, 2028–2037.PubMedGoogle Scholar
  25. 25.
    Berlin, C., Bargatze, R. F., Campbell, J. J., Von Andrian, U. H., Szabo, M. C., Hasslen, S. R., Nelson, R. D., Berg, E. L., Erlandsen, S. L & Butcher, E. C. (1995): α4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80, 413–422.PubMedCrossRefGoogle Scholar
  26. 26.
    Bird, M. I., Foster, M. R., Priest, R. & Malhotra, R. (1997): Selectins: physiological and pathophysiological roles. Biochem. Soc. Trans. 25, 1199–1206.PubMedGoogle Scholar
  27. 27.
    Björk, S., Breimer, M. E., Hansson, G. C., Karlsson, K. A. & Leffler, H. (1987): Structures of blood group glycosphingolipids of human small intestine. A relation between the expression of fucolipids of epithelial cells and the ABO, Le, and Se phenotype of the donor. J. Biol. Chem. 262, 6758–6765.PubMedGoogle Scholar
  28. 28.
    Blaineau, C., Le Pendu, J., Arnaud, D., Connan, F. & Avner, P. (1983): The glycosidic antigen recognized by a novel monoclonal antibody, 75.12, is developmentally regulated on mouse embryonal carcinoma cells. EMBO J. 2, 2217–2222.PubMedGoogle Scholar
  29. 29.
    Blaszczyk, M., Hansson, G. C., Karlsson, K. A., Larson, G., Stromberg, N., Thurin, J., Herlyn, M., Steplewski, Z. & Koprowski, H. (1984): Lewis blood group antigens defined by monoclonal anti-colon carcinoma antibodies. Arch. Biochem. Biophys. 233, 161–168.PubMedCrossRefGoogle Scholar
  30. 30.
    Blaszczyk, M., Pak, K. Y., Herlyn, M., Sears, H. F. & Steplewski, Z. (1985): Characterization of Lewis antigens in normal colon and gastrointestinal adenocarcinomas. Proc. Natl. Acad. Sci. USA 82, 3552–3556.PubMedCrossRefGoogle Scholar
  31. 31.
    Blaszczyk-Thurin, M., Sarnesto, A., Thurin, J., Hidsgaul, O. & Koprowski, H. (1988): Biosynthetic pathways for the Leb and Y glycolipids in the gastric carcinoma cell line KATO III as analyzed by a novel assay. Biochem. Biophys. Res. Commun. 151, 100–108.PubMedCrossRefGoogle Scholar
  32. 32.
    Blaszczyk-Thurin, M., Thurin, J., Hindsgaul, O., Karlsson, K. A., Steplewski, Z. & Koprowski, H. (1987): Y and blood group B type 2 glycolipid antigens accumulate in a human gastric carcinoma cell line as detected by monoclonal antibody. Isolation and characterization by mass spectrometry and NMR spectroscopy. J. Biol. Chem. 262, 372–379.PubMedGoogle Scholar
  33. 33.
    Boettcher, B. & Kenny, R. (1971): A quantitative study of Lea, A, and H antigens in salivas of Australian Caucasians and Aborigines. Hum. Hered. 21, 334–345.PubMedCrossRefGoogle Scholar
  34. 34.
    Borén, T., Falk, P., Roth, K. A., Larson, Q. & Normark, S. (1993): Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 262, 1892–1895.PubMedCrossRefGoogle Scholar
  35. 35.
    Bovin, N. V. & Khorlin, A. Y. (1985): Convenient synthon for preparing Le and ABH blood group determinants. Bioorg. Khim. 11, 826–829.PubMedGoogle Scholar
  36. 36.
    Brandley, B. K., Swiedler, S. J. & Robbins, P. W. (1990): Carbohydrate ligands of the LEC cell adhesion molecules. Cell 63, 861–863.PubMedCrossRefGoogle Scholar
  37. 37.
    Breimer, M. E., Karlsson, K. A. & Samuelsson, B. E. (1982): Characterization of a human intestinal difucosyl heptaglycosylceramide with a blood group B determinant and a type 1 carbohydrate chain. J. Biol. Chem. 257, 1079–1085.PubMedGoogle Scholar
  38. 38.
    Brendemoen, O. J. (1950): Further studies of agglutination and inhibition in the Lea-Lea system. J. Lab. Clin. Med. 36, 335–341.PubMedGoogle Scholar
  39. 39.
    Brendemoen, O. J. (1961): Development of the Lewis blood group in the newborn. Ada Pathol. Micmbiol. Scand. 52, 55–58.CrossRefGoogle Scholar
  40. 40.
    Breton, C., Oriol, R. & Imberty, A. (1998): Conserved structural features in eukaryotic and prokaryotic fucosyltransferases. Glycobiology 8, 87–94.PubMedCrossRefGoogle Scholar
  41. 41.
    Brinkman-Van Der Linden, E. C. M., Mollicone, R., Oriol, R., Larson, G., Van Den Eijnden, D. H. & VanDljk, W. (1996): A missense mutation in the FUT6 gene results in total absence of a3-fucosylation of human α1,-acid glycoprotein. J. Biol. Chem. 271, 14492–14495.PubMedCrossRefGoogle Scholar
  42. 42.
    Britten, C. J. & Bird, M. I. (1997): Chemical modification of an α3-fucosyltransferase; definition of amino acid residues essential for enzyme activity. Biochim. Biophys. Acta 1334, 57–64.PubMedCrossRefGoogle Scholar
  43. 43.
    Britten, C. J., Van Den Eijnden, D. H., Mcdowell, W., Kelly, V. A., Witham, S. J., Edbrooke, M. R., Bird, M. I., De Vries, T. & Smithers, N. (1998): Acceptor specificity of the human leukocyte α3 fucosyltransferase: role of FucT-VII in the generation of selectin ligands. Glycobiology 8, 321–327.PubMedCrossRefGoogle Scholar
  44. 44.
    Broadberry, E. R. & Lin-Chu, M. (1991): The Lewis blood group system among Chinese in Taiwan. Hum. Hered. 41, 290–294.PubMedCrossRefGoogle Scholar
  45. 45.
    Brockhaus, M., Magnani, J. L., Blaszczyk, M., Steplewski, Z., Koprowski, H., Karlsson, K. A., Larson, G. & Ginsburg, V. (1981): Monoclonal antibodies directed against the human Leb blood group antigen. J. Biol. Chem. 256, 13223–13225.PubMedGoogle Scholar
  46. 46.
    Brockhaus, M., Magnani, J. L., Herlyn, M., Blaszczyk, M., Steplewski, Z., Koprowski, H. & Ginsburg, V. (1982): Monoclonal antibodies directed against the sugar sequence of lacto-N-fucopentaose III are obtained from mice immunized with human tumors. Arch. Biochem. Biophys. 217, 647–651.PubMedCrossRefGoogle Scholar
  47. 47.
    Brown, A., Ellis, I. O., Embleton, M. J., Baldwin, R. W., Turner, D. R. & Hardcastle, J. D. (1984): Immunohistochemical localization of Y hapten and the structurally related H type-2 blood-group antigen on large-bowel tumours and normal adult tissues. Int. J. Cancer 33, 727–736.PubMedCrossRefGoogle Scholar
  48. 48.
    Brown, A., Feizi, T., Gool, H. C., Embleton, M. J., Picard, J. K. & Baldwin, R. W. (1983): A monoclonal antibody against human colonic adenoma recognizes difucosylated type-2 blood-group chains. Biosci. Rep. 3, 163–170.PubMedCrossRefGoogle Scholar
  49. 49.
    Bruntz, R., Dabrowski, U., Dabrowski, J., Ebersold, A., Peter-Katalinic, J. & Egge, H. (1988): Fucose-containing oligosaccharides from human milk from a donor of blood group O Lea nonsecretor. Biol. Chem. Hoppe-Seyler 369, 257–273.PubMedCrossRefGoogle Scholar
  50. 50.
    Buerke, M., Weyrich, A. S., Zheng, Z., Gaeta, F. C., Forrest, M. J. & Lefer, A. M. (1994): Sialyl Lewisx-containing oligosaccharide attenuates myocardial reperfusion injury in cats. J. Clin. Invest. 93, 1140–1148.PubMedCrossRefGoogle Scholar
  51. 51.
    Cagas, P. & Bush, C. A. (1990): Determination of the conformation of Lewis blood group oligosaccharides by simuloation of two-dimensional nuclear Overhauser data. Biopolymers 30, 1123–1138.PubMedCrossRefGoogle Scholar
  52. 52.
    Caillard, T., Le Pendu, J., Ventura, M., Mada, M., Rault, G., Mannoni, P. & Oriol, R. (1988): Failure of expression of α-3-L-fucosyltransferase in human serum is coincident wit the absence of the X (or Lex)antigen in the kidney but not on leucocytes. Exp. Clin. Immunogenet. 5, 15–23.PubMedGoogle Scholar
  53. 53.
    Cameron, H. S., Szczepaniak, D. & Weston, B. W. (1995): Expression of human chromosome 19p α(1,3)-fucosyltransferase genes in normal tissues. Alternative splicing, polyadenylation, and isoforms. J. Biol. Chem. 270, 20112–20122.PubMedCrossRefGoogle Scholar
  54. 54.
    Candelier, J. J., Mollicone, R., Mennesson, B., Bergemer, A. M., Henry, S., Coullin, P. & Oriol, R. (1993): α-3-Fucosyltransferases and their glycoconjugate antigen products in the developing human kidney. Lab. Invest. 69, 449–459.PubMedGoogle Scholar
  55. 55.
    Capron, A., Dessaint, J. P., Capron, m., Ouma, J. H. & Butterworth, A. E. (1987): Immunity to schistosomes: progress toward vaccine. Science 238, 1065–1072.PubMedCrossRefGoogle Scholar
  56. 56.
    Cartron, J. P., Mulet, C., Bauvois, B., Rahuel, C. & Salmon, C. (1980): ABH and Lewis glycosyltransferases in human red cells, lymphocytes, and platelets. Blood Transfus. Immunohaematol. 23, 271–282.CrossRefGoogle Scholar
  57. 57.
    Ceppellini, R., Dunn, L C. & Innella, F. (1959): Immunogenetjca II. Annalisi genetica formale de caratteri Lewis con particolare riguardo alia natura epistatica delta specificita serologica Leb. Fol. Hered. Pathol. 8, 261–296.Google Scholar
  58. 58.
    Ceppellini, R. & Siniscalco, M. (1955): Una nuova ipotesi genetica per il sistema Lewis secretore e suoi riflessi nei riguardi di alcune evidence di linkage con altri loci. Rev. 1st. Sieroterap. ltal. 30, 431–445.Google Scholar
  59. 59.
    Chandrasekaran, E. V., Jain, R. K., Rhodes, J. M., Srnka, C. A., Larsen, R. D. & Matta, K. L. (1995): Expression of blood group Lewis b determinant from Lewis a: association of this novel α(1,2)-L-fucosylating activity with the Lewis type α(1,3/4)-L-fucosyltransferase. Biochemistry 34, 4748–4756.PubMedCrossRefGoogle Scholar
  60. 60.
    Chester, M. A. & Watkins, W. M. (1969): α-L-Fucosyltransferases in human submaxillary gland and stomach tissues associated with the H, Lea and Leb blood group characters and ABH secretor status. Biochem. Biophys. Res. Commun. 34, 835–842.PubMedCrossRefGoogle Scholar
  61. 61.
    Chmiela, M., Wadstrom, T., Folkesson, H., Malecka, I. P., Czkwianianc, E., Rechcinski, T. & Rudnicka, W. (1998): Anti-Lewis X antibody and Lewis X anti-Lewis X immune complexes in Helicobacter pylori infection. Immunol. Lett. 61, 119–125.PubMedCrossRefGoogle Scholar
  62. 62.
    Clarke, J. L. & Watkins, W. M. (1996): α1,3-L-Fucosyltransferase expression in developing human myeloid cells Antigenic, enzymatic, and mRNA analyses. J. Biol. Chem. 271, 10317–10328.PubMedCrossRefGoogle Scholar
  63. 63.
    Clausen, H., Levery, S. B., Mckibbin, J. M. & Hakomori, S. I. (1985): Blood group A determinants with mono-and difucosyl type 1 chain in human erythrocyte membranes. Biochemistry 24, 3578–3586.PubMedCrossRefGoogle Scholar
  64. 64.
    Clausen, H., Mckibbin, J. M. & Hakomori, S. I. (1985): Monoclonal antibodies defining blood group A variants with difucosyl type 1 chain (ALeb) and difucosyl type 2 chain (ALev). Biochemistry 24, 6190–6194.PubMedCrossRefGoogle Scholar
  65. 65.
    Costa, J., Costa, M. T., Grabenhorst, E., Nimtz, M. & Conradt, H. S. (1998): Construction of recombinant BHK cell lines expressing wild-type and mutants of human alpha 1,3/4-fucosyltransferase. Carbohydr. Polym. 37, 287–290.CrossRefGoogle Scholar
  66. 66.
    Costache, M., Apoil, P. A., Cailleau, A., Elmgren, A., Larson, G., Henry, S., Blancher, A., Iordachescu, D., Oriol, R. & Mollicone, R. (1997): Evolution of fucosyltransferase genes in vertebrates. J. Biol. Chem. 272, 29721–29728.PubMedCrossRefGoogle Scholar
  67. 67.
    Coté, R. H. & Valet, J. P. (1976): Isolation, composition, and reactivity of the neutral glycoproteins from human meconiums with specificities of the ABO and Lewis systems. Biochem. J. 153, 63–73.PubMedGoogle Scholar
  68. 68.
    Cowles, J. W., Spitalnik, S. L & Blumberg, N. (1986): Detection of anti-Lea in Le(a-b+) individuals by kinetic ELISA. Vox Sang. 50, 164–168.PubMedCrossRefGoogle Scholar
  69. 69.
    Crawley, S. C., Hindsgaul, O., Ratcliffe, R. M., Lamontagne, L R. & Palcic, M. M. (1989): A plant fucosyltransferase with human Lewis blood-group specificity. Carbohydr. Res. 193, 249–256.PubMedCrossRefGoogle Scholar
  70. 70.
    Crookston, M. C., Tilley, C. A. & Crookston, J. H. (1970): Human blood chimaera with seeming breakdown of immune tolerance. Lancet ii, 1110–1112.CrossRefGoogle Scholar
  71. 71.
    Cutbush, M., Giblett, E. R. & Moujson, P. L (1956): Demonstration of the phenotype Le(a+b+) in infants and adults. Brit. J. Haematol. 2, 210–213.CrossRefGoogle Scholar
  72. 72.
    Dabrowski, J., Hanfland, P., Egge, H. & Dabrowski, U. (1981): Immunochemistry of the Lewis-blood-group system: proton nuclear magnetic resonance study of plasmatic Lewis-blood-group-active glycosphingolipids and related substances. Arch. Biochem. Biophys. 210, 405–411.PubMedCrossRefGoogle Scholar
  73. 73.
    Dakour, J., Lundblad, A. & Zopf, D. (1988): Detection and isolation of oligosaccharides with Lea and Leb blood group activities by affinity chromatography using monoclonal antibodies. Arch. Biochem. Biophys. 264, 203–213.PubMedCrossRefGoogle Scholar
  74. 74.
    Damian, R. T. (1987): The exploitation of host immune responses by parasites. J. Parasitol. 73, 3–13.PubMedCrossRefGoogle Scholar
  75. 75.
    De Bose-Boyd, R., Nyame, A. K. & Cummings, R. D. (1996): Schistosoma mansoni: characterization of an a1-3 fucosyltransferase in adult parasites. Exp. Parasitol. 82, 1–10.CrossRefGoogle Scholar
  76. 76.
    De Vries, T., Srnka, C. A., Palcic, M. M., Swiedler, S. J., Van Den Eijnden, D. H. & Macher, B. A. (1995): Acceptor specificity of different length constructs of human recombinant α1,3/4-fucosyltransferases. Replacement of the stem region and the transmembrane domain of fucosyltransferase V by protein A results in an enzyme with GDP-fucose hydrolyzing activity. J. Biol. Chem. 270, 8712–8722.PubMedCrossRefGoogle Scholar
  77. 77.
    Dinh, Q., Weng, N. P., Kiso, M., Ishida, H., Hasegawa, A. & Marcus, D. M. (1996): High affinity antibodies against Lex and sialyl Le” from a phage display library. J. Immunol. 157, 732–738.PubMedGoogle Scholar
  78. 78.
    Dissous, C., Grzych, J. M. & Capron, A. (1986): Schistosoma mansoni shares a protective oligosaccharide epitope with freshwater and marine snails. Nature 323, 443–445.PubMedCrossRefGoogle Scholar
  79. 79.
    Dorf, M. E., Eguro, S. Y., Cabrera, G., Yunis, E. J., Swanson, J. & Amos, D. B. (1972): Detection of cytotoxic non-HL-A antisera. I. Relationship to anti-Lea. Vox Sang. 22, 447–456.PubMedCrossRefGoogle Scholar
  80. 80.
    Dunstan, R. A., Simpson, M. B. & Rosse, W. F. (1985): Le” blood group antigen on human platelets. Amer. J. Clin. Pathol. 83, 90–94.Google Scholar
  81. 81.
    Dupuy, F., Petit, J. M., Mollicone, R., Oriol, R., Julien, R. & Maftah, A. (1999): A single amino acid in the hypervariable stem domain of vertebrate α1,3/1,4-fucosyltransferases determines the type 1 / type 2 transfer. Characterization of acceptor substrate specificity of the Lewis enzyme by site-directed mutagenesis. J. Biol. Chem. 274, 12257–12262.PubMedCrossRefGoogle Scholar
  82. 82.
    Egge, H., Dell, A. & Von Nicolai, H. (1983): Fucose containing oligosaccharides from human milk. I. Separation and identification of new constituents. Arch. Biochem. Biophys. 224, 235–253.PubMedCrossRefGoogle Scholar
  83. 83.
    Egge, H. & Hanfland, P. (1981): Immunochemistry of the Lewis-blood-group-system. Mass spectrometric analysis of permethylated Lea-, Leb-, and H-type 1 (LedH) blood-group active and related glycosphingolipids from human plasma. Arch. Biochem. Biophys. 210, 396–404.PubMedCrossRefGoogle Scholar
  84. 84.
    Eggens, I., Fenderson, B., Toyokuni, T., Dean, B., Stroud, M. & Hakomori, S. I. (1989): Specific interaction between Lex and Lex determinants. A possible basis for cell recognition in preimplanataion embryos and in embryonal carcinoma cells. J. Biol. Chem. 264, 9476–9484.PubMedGoogle Scholar
  85. 85.
    Elmgren, A., Börjeson, C., Svensson, L., Rydberg, L. & Larson, G. (1996): DNA sequencing and screening for point mutations in the human Lewis (FUT3) gene enables molecular genotyping of the human Lewis blood group system. Vox Sang. 70, 97–103.PubMedCrossRefGoogle Scholar
  86. 86.
    Elmgren, A., Mollicone, R., Costache, M., Börjeson, C., Oriol, R., Harrington, J. & Larson, G. (1997): Significance of individual point mutations, T202C and C314T, in the human Lewis (FUT3) gene for expression of Lewis antigens by the human α(1,3/1,4)-fucosyltransferase, Fuc-TIII. J. Biol. Chem. 272, 21994–21998.PubMedCrossRefGoogle Scholar
  87. 87.
    Elmgren, A., Rydberg, L. & Larson, G. (1993): Genotypic heterogeneity among Lewis-negative individuals. Biochem. Biophys. Res. Commun. 196, 515–520.PubMedCrossRefGoogle Scholar
  88. 88.
    Eppenberger-Castori, S., Lotscher, H. & Finne, J. (1989): Purification of the N-acetyiglucosaminide α(1-3/4)fucosyltransferase of human milk. Glycoconj. J. 6, 101–114.PubMedCrossRefGoogle Scholar
  89. 89.
    Ernst, C., Atkinson, B., Wysocka, M., Blaszczyk, M., Herlyn, M., Sears, H., Steplewski, Z. & Koprowski, H. (1984): Monoclonal antibody localization of Lewis antigens in fixed tissue. Lab. Invest. 50, 394–400.PubMedGoogle Scholar
  90. 90.
    Falk, K. E., Karlsson, K. A. & Samuelsson, B. E. (1979): Proton nuclear magnetic resonance analysis of anomeric structure of glycosphingolipids. Lewis-active and Lewis-like substances. Arch. Biochem. Biophys. 192, 191–202.PubMedCrossRefGoogle Scholar
  91. 91.
    Falk, P. G., Bry, L., Holgersson, J. & Gordon, J. I. (1995): Expression of a human α-1,3/4-fucosyltransferase in the pit cell lineage of FVB/N mouse stomach results in production of Leb-containing glycoconjugates: a potential transgenic mouse model for studying Helicobacter pylori infection. Proc. Natl. Acad. Sci. USA 92, 1515–1519.PubMedCrossRefGoogle Scholar
  92. 92.
    Feizi, T. (1985): Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens. Nature 314, 53–57.PubMedCrossRefGoogle Scholar
  93. 93.
    Feizi, T. & Childs, R. A. (1985): Carbohydrate structures of glycoproteins and glycolipids as differentiation antigens, tumour-associated antigens and components of receptor systems. Trends Biochem. Sci. 10, 24–29.CrossRefGoogle Scholar
  94. 94.
    Finne, J., Breimer, M. E., Hansson, G. C., Karlsson, K. A., Leffler, K, Vliegenthart, J. F. G. & VanHalbeek, H. (1989): Novel polyfucosylated N-linked glycopeptides with blood group A, H, X, and Y determinants from human small intestinal epithelial cells. J. Biol. Chem. 264, 5720–5735.PubMedGoogle Scholar
  95. 95.
    Foster, C. S., Gillies, D. R. B. & Glick, M. C. (1991): Purification and characterization of GDP-L-Fuc-N-acetyl-β-D-glucosaminide α1 →3 fucosyltransferase from human neuroblastoma cells. Unusual substrate specificities of the tumor enzyme. J. Biol. Chem. 266, 3526–3531.PubMedGoogle Scholar
  96. 96.
    Fox, N., Damjanov, I., Knowles, B. B. & Solter, D. (1983): Immunohistochemical localization of the mouse stage-specific embryonic antigen 1 in human tissues and tumors. Cancer Res. 43, 669–678.PubMedGoogle Scholar
  97. 97.
    François, A., Sansonetti, N., Mollicone, R., Le Pendu, J., Galton, J., Jaulmes, B. & Oriol, R. (1986): Heterogeneity of Lewis antibodies. A comparison of the reaction of human and animal reagents with synthetic oligosaccharides. Vox Sang. 50, 227–234.PubMedCrossRefGoogle Scholar
  98. 98.
    Fraser, R. H., Allan, E. K., Murphy, M. T., Inglis, G. & Mitchell, R. (1990): Monoclonal anti-Lea and anti-Leb: serological and immunochemical characterization. 2nd Int. Workshop on Human Red Blood Cell Antigens, Lund, Sweden, Abstract p. 73.Google Scholar
  99. 99.
    Fredman, P., Rlchert, N. D., Magnani, J. L., Wlllingham, M. C., Pastan, I. & Glnsburg, V. (1983): A monoclonal antibody that precipitates the glycoprotein receptor for epidermal growth factor is directed against the human blood group H type 1 antigen. J. Biol. Chem. 258, 11206–11210.PubMedGoogle Scholar
  100. 100.
    Fukuda, M. (1985): Cell surface glycoconjugates as onco-differentiation markers in hematopoietic cells. Biochim. Biophys. Acta 780, 119–150.PubMedGoogle Scholar
  101. 101.
    Fukuda, M., Spooncer, E., Oates, J. E., Dell & Klock, J. C. (1984): Structure of sialylated fucosyl lactosaminoglycan isolated from human granulocytes. J. Biol. Chem. 259, 10925–10935.PubMedGoogle Scholar
  102. 102.
    Fukuda, M. N., Dell, A., Oates, J. E., Wu, P., Klock, J. C. & Fukuda, M. (1985): Structures of glycosphingolipids isolated from human granulocytes. The presence of a series of linear poly-N-acetyllactosaminylceramide and its significance in glycolipids of whole blood cells. J. Biol. Chem. 260, 1067–1082.PubMedGoogle Scholar
  103. 103.
    Fukushi, Y., Hakomori, S. I., Nudelman, E. & Cochran, N. (1984): Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain. J. Biol. Chem. 259, 4681–4685.PubMedGoogle Scholar
  104. 104.
    Fukushi, Y., Hakomori, S. I. & Shepard, T. (1984): Localization and alteration of mono-, di-, and trifucosyl α1 →3 type 2 chain structures during human embryogenesis and in human cancer. J. Exp. Med. 160, 506–520.PubMedCrossRefGoogle Scholar
  105. 105.
    Fukushi, Y., Nudelman, E., Levery, S. B., Hakomori, S. I. & Rauvala, H. (1984): Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3-NeuAcV3HI3Fuc2nLc6). J. Biol. Chem. 259,10511–10517.PubMedGoogle Scholar
  106. 106.
    Fukushima, K., Hlrota, M., Terasaki, P. A., Wakisaka, A., Togashi, H., Chia, D., Suyama, N., Fukushi, Y., Nudelman, E. M. & Hakomori, S. I. (1984): Characterization of sialosylated Lewis” as a new tumor-associated antigen. Cancer Res. 44, 5279–5285.PubMedGoogle Scholar
  107. 107.
    Fukuta, S., Magnani, J. L., Gaur, P. K. & Ginsburg, V. (1987): Monoclonal antibody CC3C195, which detects cancer-associated antigens in serum, binds to the human Le” blood group antigen and to its sialylated derivative. Arch. Biochem. Biophys. 255, 214–216.PubMedCrossRefGoogle Scholar
  108. 108.
    Geyer, A., Gege, C. & Schmidt, R. R. (1999): Carbohydrate-carbohydrate recognition between Lewis” glycoconjugates. Angew. Chem. Int. Ed. 38, 1466–1468.CrossRefGoogle Scholar
  109. 109.
    Ginsburg, V., Mcginlss, M. H. & Zopf, D. A. (1980): Biochemical basis for some bloood groups. In: Immunobiology of the Erythrocyte (S. G. Sandier, J. Nusbacher, and M. S. Schanfield, eds.). Alan R. Liss Inc., New York, pp. 45–53.Google Scholar
  110. 110.
    Goeltz, S. E., Hession, C., Goff, D., Griffiths, B., Tizard, R., Newman, B., Chi-Rosso, G. & Lobb, R. (1990): ELFT: a gene that directs the expression of an ELAM-1 ligand. Cell 63, 1349–1356.CrossRefGoogle Scholar
  111. 111.
    Good, A. H., Yau, O., Lamontagne, L. R. & Oriol, R. (1992): Serological and chemical specificities of twelve monoclonal anti-Lea and antj-Leb antibodies. Vox Sang. 62, 180–189.PubMedCrossRefGoogle Scholar
  112. 112.
    Gooi, H. C., Feizi, T., Kapadia, A., Knowles, B. B., Solter, D. & Evans, M. J. (1981): Stage-specific embryonic antigen involves α1 →3 fucosylated type 2 blood group chains. Nature 292, 156–158.PubMedCrossRefGoogle Scholar
  113. 113.
    Gooi, H. C, Picard, J. K., Hounsell, E. F., Gregoriou, M., Rees, A. R. & Feizi, T. (1985): Monoclonal antibody (EGR/G49) reactive with the epidermal growth factor receptor of A431 cells recognizes the blood group Ab and ALey structures. Mol.. Immunol. 22, 689–694.PubMedCrossRefGoogle Scholar
  114. 114.
    Grabenhorst, E., Nimtz, M., Costa, J. & Conradt, H. S. (1998): In vivo specificity of human α1,3/4-fucosyltransferases III-VII in the biosynthesis of Lewis” and sialyl Lewis” motifs on complex-type N-glycans.Coexpression studies from BHK-21 cells together with human β-trace protein. J. Biol. Chem. 273, 30985–30994.PubMedCrossRefGoogle Scholar
  115. 115.
    Graham, D. Y. (1991): Helicobacter pylori: its epidemiology and its role in duodenal ulcer disease. J. Gastroenterol. Hepatol. 6, 105–113.PubMedCrossRefGoogle Scholar
  116. 116.
    Graham, H. A., Hirsch, H. F. & Davies, D. M. (1977): Genetics and immunochemical relationships between soluble and cell-bound antigens of the Lewis system. In: Human Blood Groups. (J. F. Mohn, R. W. Plunkett, R. K. Cunningham, and R. M. Lambert, eds.). S. Karger, Basel, pp. 257–267.Google Scholar
  117. 117.
    Graham, H. A., Sina, P., Hirsch, H. F. & Jacquinet, J. C. (1978): Inhibition of anti-LedH and Ulex anti-H lectin with oligosaccharides. XVth Congress of the International Society of Blood Transfusion, Paris, Abstract p. 542.Google Scholar
  118. 118.
    Green, P. J., Tamatani, T., Watanabe, T., Miyasaka, M., Hasegawa, A., Kiso, M., Yuen, C. T., Stoll, M. S. & Feizi, T. (1992): High affinity binding of the leucocyte adhesion molecule L-selectin to 3′-sulphated-Lea and 3′-sulphated-Le” oligosaccharides and the predominance of sulphate in this interaction demonstrated by binding studies with a series of lipid-linked oligosaccharides. Biochem. Biophys. Res. Commun. 188, 244–251.PubMedCrossRefGoogle Scholar
  119. 119.
    Green Well, P., Ball, M. G. & Watkins, W. M. (1983): Fucosyltransferase activity in human lymphocytes and granulocytes. Blood group H-gene-specified α-2-L-fucosyltransferase is a discriminatory marker of peripheral blood lymphocytes. FEBS Lett. 164, 314–317.CrossRefGoogle Scholar
  120. 120.
    Grollman, E. F., Kobata, A. & Ginsburg, V. (1969): An enzymatic basis for Lewis blood types in man. J. Clin. Invest. 48, 1489–1494.PubMedCrossRefGoogle Scholar
  121. 121.
    Grönberg, G., Lipniunas, P., Lundgren, T., Lindh, F. & Nilsson, B. (1992): Structural analysis of five new monosialylated oligosaccharides from human milk. Arch. Biochem. Biophys. 296, 597–610.PubMedCrossRefGoogle Scholar
  122. 122.
    Grubb, R. (1948): Correlation between Lewis blood group and secretor character in man. Nature 162, 933.PubMedCrossRefGoogle Scholar
  123. 123.
    Grubb, R. (1951): Observations on the human group system Lewis. Ada Pathol. Microbiol. Scand. 28, 61–81.CrossRefGoogle Scholar
  124. 124.
    Gundolf, F. (1973): Anti-A,Leb in serum of a person of a blood group A1h. Vox Sang. 25, 411–419.PubMedCrossRefGoogle Scholar
  125. 125.
    Gunson, H. H. & Latham, V. (1972): An agglutinin in human serum reacting with cells from Le(a-b-) non-secretor individuals. Vox Sang. 22, 344–353.PubMedCrossRefGoogle Scholar
  126. 126.
    Hakomori, S. I. (1986): Tumor-associated glycolipid antigens, their metabolism and organization. Che/77. Phys. Lipids 42, 209–233.CrossRefGoogle Scholar
  127. 127.
    Hakomori, S. I. (1989): Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv. Cancer. Res. 52, 257–331.PubMedCrossRefGoogle Scholar
  128. 128.
    Hakomori, S. I. (1992): Le” and related structures as adhesion molecules. Histochem. J. 24, 771–776.PubMedCrossRefGoogle Scholar
  129. 129.
    Hakomori, S. I. & Andrews, H. D. (1970): Sphingolipids with Le” activity and the copresence of Le” and Leb glycolipids in human tumor tissue. Biochim. Biophys. Ada 202, 225–228.CrossRefGoogle Scholar
  130. 130.
    Hakomori, S. I. & Kannagi, R. (1983): Glycosphingolipids as tumor-associated and differentiation markers. J. Natl. Cancer Inst. 71, 231–251.PubMedGoogle Scholar
  131. 131.
    Hakomori, S. I. & Kobata, A. (1974): Blood group antigens. In: The Antigens (M. S. Sela, ed.). Academic Press, New York, Vol. 2, pp. 79–140.Google Scholar
  132. 132.
    Hakomori, S. I., Nudelman, E., Kannagi, R. & Levery, S. B. (1982): The common structure in fucosyllactosaminolipids accumulating in human adenocarcinomas, and its possible absence in normal tissue. Biochem. Biophys. Res. Commun. 109, 36–44.PubMedCrossRefGoogle Scholar
  133. 133.
    Hakomori, S. I., Nudelman, E., Levery, S., Solter, D. & Knowles, B. B. (1981): The hapten structure of a developmentally regulated glycolipid antigen (SSEA-1) isolated from human erythrocytes and adenocarcinoma: a preliminary note. Biochem. Biophys. Res. Commun. 100, 1578–1586.PubMedCrossRefGoogle Scholar
  134. 134.
    Hakomori, S. I., Nudelman, E., Levery, S. B. & Kannagi, R. (1984): Novel fucolipids accumulating in human adenocarcinoma. I. Glycolipids with di-or trifucosylated type 2 chain. J. Biol. Chem. 259, 4672–4680.PubMedGoogle Scholar
  135. 135.
    Hammar, L., Mansson, S., Rohr, T., Chester, M. A., Ginsburg, V., Lundblad, A. & Zopf, D. (1981): Lewis phenotype of erythrocytes and Leb-active glycolipid in serum of pregnant women. Vox Sang. 40, 27–33.PubMedCrossRefGoogle Scholar
  136. 136.
    Handa, K., Withers, D. A. & Hakomori, S. (1998): The α1→3 fucosylation at the penultimate GlcNAc catalyzed by fucosyltransferase VII is blocked by internally fucosylated residue in sialosyl long-chain poly-LacNAc: enzymatic basis for expression of physiological E-selectin epitope. Biochem. Biophys. Res. Commun. 243, 199–204.PubMedCrossRefGoogle Scholar
  137. 137.
    Hanfland, P. (1978): Isolation and purification of Lewis blood-group active glycosphingolipids from the plasma of human O Leb individuals. Eur. J. Biochem. 87, 161–170.PubMedCrossRefGoogle Scholar
  138. 138.
    Hanfland, P. & Graham, H. A. (1981): Immunochemistry of the Lewis-blood-group system: partial characterization of Lea-, Leb-, and H-type 1 (LedH)-blood-group active glycosphingolipids from human plasma. Arch. Biochem. Biophys. 210, 383–395.PubMedCrossRefGoogle Scholar
  139. 139.
    Hanfland, P., Graham, H. A., Crawford, R. J. & Schenkel-Brunner, H. (1982): Immunochemistry of the Lewis blood group system. Investigations on the Lec antigen. FEBS Lett. 142, 77–80.PubMedCrossRefGoogle Scholar
  140. 140.
    Hanfland, P., Kladetzky, R. G. & Egli, G. (1978): Isolation and purification of Le3 blood-group active and related glycosphingolipids from human plasma of blood group A Lea individuals. Chem. Phys. Lipids 22, 141–151.PubMedCrossRefGoogle Scholar
  141. 141.
    Hanfland, P., Kordowicz, M., Peter-Katalinic, J., Pfannschmidt, G., Crawford, R. J., Graham, H. A. & Egge, H. (1986): Immunochemistry of the Lewis blood-group system: isolation and structures of Lewis-c active and related glycosphingolipids from the plasma of blood-group O Le(a-b-) nonsecretors. Arch. Biochem. Biophys. 246, 655–672.PubMedCrossRefGoogle Scholar
  142. 142.
    Hanisch, F. G., Egge, H., Peter-Katalinic, J. & Uhlenbruck, G. (1986): Primary structure of a major sialyl-saccharide alditol from human amniotic mucins expressing the tumor-associated sialyl-X antigenic determinant. FEBS Lett. 200, 42–46.PubMedCrossRefGoogle Scholar
  143. 143.
    Hanisch, F. G., Mitsakos, A., Schroten, H. & Uhlenbruck, G. (1988): Biosynthesis of cancer-associated sialyl-X antigen by a (1→3)-α-L-fucosyltransferase of human amniotic fluid. Carbohydr. Res. 178, 23–28.PubMedCrossRefGoogle Scholar
  144. 144.
    Hanisch, F. G., Uhlenbruck, G. & Dienst, C. (1984): Structure of tumor-associated carbohydrate antigen Ca 19-9 on human seminal-plasma glycoproteins from healthy donors. Eur. J. Biochem. 144, 467–473.PubMedCrossRefGoogle Scholar
  145. 145.
    Hansson, G. C., Karlsson, K. A., Larson, G., Mckibbin, J. M., Blaszczyk, M., Herlyn, M., Steplewski, Z. & Koprowski, H. (1983): Mouse monoclonal antibodies against human cancer cell lines with specificities for blood group and related antigens. J. Biol. Chem. 258, 4091–4097.PubMedGoogle Scholar
  146. 146.
    Hansson, G. C. & Zopf, D. (1985): Biosynthesis of the cancer-associated sialyl-Lea antigen. J. Biol. Chem. 260, 9388–9392.PubMedGoogle Scholar
  147. 147.
    Hemmerich, S., Bertozzi, C. R., Leffler, H. & Rosen, S. D. (1994): Identification of the sulfated monosaccharides of GlyCAM-1, an endothelial-derived ligand for L-selectin. Biochemistry 33, 4820–4829.PubMedCrossRefGoogle Scholar
  148. 148.
    Henry, S., Jovall, P. Å., Ghardashkhani, S., Elmgren, A., Martinsson, T., Larson, G. & Samuelsson, B. (1997): Structural and immunochemical identification of Lea, Leb, H type 1, and related glycolipids in small intestinal mucosa of a group O Le(a-b-) nonsecretor. Glycoconj. J. 14, 209–223.PubMedCrossRefGoogle Scholar
  149. 149.
    Henry, S. M., Benny, A. G. & Woodfiled, D. G. (1990): Investigation of Lewis phenotypes on Polynesians: evidence of a weak secretor phenotype. Vox Sang. 58, 61–66.PubMedCrossRefGoogle Scholar
  150. 150.
    Henry, S. M., Jovall, P. A., Ghardashkhani, S., Gustavsson, M. L. & Samuelsson, B. E. (1995): Structural and immunochemical identification of Leb glycolipids in the plasma of a group O Le(a-b-) secretor. Glycocon. J. 12, 309–317.CrossRefGoogle Scholar
  151. 151.
    Henry, S. M., Oriol, R. & Samuelsson, B. E. (1994): Detection and characterization of Lewis antigens in plasma of Lewis-negative individuals. Evidence of chain extension as a result of reduced fucosyltransferase competition. Vox Sang. 67, 387–396.PubMedCrossRefGoogle Scholar
  152. 152.
    Henry, S. M., Simpson, L A. & Woodfield, D. G. (1988): The Le(a+b+) phenotype in Polynesians. Hum. Hered. 38, 111–116.PubMedCrossRefGoogle Scholar
  153. 153.
    Henry, S. M., Woodfield, D. G., Samuelsson, B. E. & Oriol, R. (1993): Plasma and red-cell glycolipid patterns of Le(a+b+) and Le(a+b-) Polynesians as further evidence of the weak secretor gene Sew. Vox Sang. 65, 62–69.PubMedCrossRefGoogle Scholar
  154. 154.
    Herlyn, M., Sears, Steplewski, Z. & Koprowski, H. (1982): Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinoma. J. Clin. Immunol. 2, 135–140.PubMedCrossRefGoogle Scholar
  155. 155.
    Hindsgaul, O., Norberg, T., Le Pendu, J. & Lemieux, R. U. (1982): Synthesis of type 2 human blood group antigenic determinants. The H, X, and Y haptens and variations of the H type 2 determinants as probes for the combining site of the lextin I of Ulex europaeus. Carbohydr. Res. 109, 109–142.PubMedCrossRefGoogle Scholar
  156. 156.
    Hirsch, H. F. & Graham, H. A. (1980): Adsorption of Lec and Leb from plasma onto red blood cells. Transfusion 20, 474–475.PubMedCrossRefGoogle Scholar
  157. 157.
    Holburn, A. M. (1974): IgG Anti-Lea. Brit. J. Haematol. 27, 489–500.CrossRefGoogle Scholar
  158. 158.
    Holmes, E. H. & Levery, S. B. (1989): Biosynthesis fo fucose containing iacto-series glycolipids in human colonic adenocyreinoma Colo 205 cells. Arch. Biochem. Biophys. 274, 633–647.PubMedCrossRefGoogle Scholar
  159. 159.
    Holmes, E. H., Ostrander, G. K., Clausen, H. & Graem, N. (1987): Oncofetal expression of Le* carbohydrate antigens in human colonic adenocarcinomas. Regulation through type 2 core chain synthesis rather than fucosylation. J. Biol. Chem. 262, 11331–11338.PubMedGoogle Scholar
  160. 160.
    Holmes, E. H., Ostrander, G. K. & Hakomori, S. I. (1985): Enzymatic basis for the accumulation of glycolipids with X and dimeric X determinants in human lung cancer cells (NCI-H69). J. Biol. Chem. 260, 7619–7627.PubMedGoogle Scholar
  161. 161.
    Holmes, E. H., Ostrander, G. K. & Hakomori, S. I. (1986): Biosynthesis of the sialyl-Le determinant carried by type 2 chain glycosphingolipids (IV3NeuAclll3FucnLc4, VI3NeuAcV3FucnLc6, and VI3NeuAclll3V3Fuc2nLc6) in human lung carcinoma PC9 cells. J. Biol. Chem. 261, 3737–3743.PubMedGoogle Scholar
  162. 162.
    Holmes, E. H., Xu, Z. H., Sherwood, A. L. & Macher, B. A. (1995): Structure-function analysis of human α1→3 fucosyltransferases.A GDP-fucose-protected, N-ethylmaleimide-sensitive site in FucT-lll and FucT-V corresponds to Ser178 in FucT-IV. J. Biol. Chem. 270, 8145–8151.PubMedCrossRefGoogle Scholar
  163. 163.
    Huang, L. C., Brockhaus, M., Magnani, J. L., Cuttitta, F., Rosen, S., Minna, J. D. & Ginsburg, V. (1983): Many monoclonal antibodies with an apparent specificity for certain lung cancers are directed against a sugar sequence found in lacto-N-fucopentaose III. Arch. Biochem. Biophys. 220, 318–320.PubMedCrossRefGoogle Scholar
  164. 164.
    Ikehara, Y., Nlshihara, S., Kudo, T., Hlraga, T., Morozumi, K., Hattori, T. & Narimatsu, H. (1998): The aberrant expression of Lewis a antigen in intestinal metaplastic cells of gastric mucosa is caused by augmentation of Lewis enzyme expression. Glycoconj. J. 15, 799–807.PubMedCrossRefGoogle Scholar
  165. 165.
    Ilver, D., Arnqvist, A., ögren, J., Frick, I. M., Kersulyte, D., Incecik, E. T., Berg, D. E., Covacci, A., Engstrand, L. & Borén, T. (1998): Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279, 373–377.PubMedCrossRefGoogle Scholar
  166. 166.
    Imai, Y., Lasky, L. A. & Rosen, S. D. (1993): Sulphation requirement for GlyCAM-1, an endothelial ligand for L-selectin. Nature 361, 555–557.PubMedCrossRefGoogle Scholar
  167. 167.
    Iseki, S., Masaki, S. & Shibasaki, K. (1957): Studies on Lewis blood group system. I. Lec blood group factor. Proc. Imp. Acad. Japan 33, 492–497.Google Scholar
  168. 168.
    Issitt, P. D. (1985): The Lewis system. In: Applied Blood Group Serology. Montgomery Scientific Publications, Miami, Florida, USA, pp. 169–191.Google Scholar
  169. 169.
    Iwaki, Y., Kasai, M., Terasaki, P. I., Bernoko, D., Park, M. S., Cicciarelli, J., Heintz, R., Saxton, R. E., Burk, M. W. & Morton, D. L. (1982): Monoclonal antibody against A,Lewisd antigen produced by the hybridoma immunized with a pulmonary carcinoma. Cancer Res. 42, 409–411.PubMedGoogle Scholar
  170. 170.
    Jacquinet, J. C. & Sinay, P. (1977): Synthesis of blood-group substances. 6. Synthesis of 0-α-L-fucopyranosyl-(1-2)-0-β-D-galactopyranosyl-(1-4)-0-(a-L-fucopyranosyl-(1-3))-2-acet-amido-2-deoxy-α-D-glucopyranoside, the postulated Lewis d antigenic determinant. J. Org. Chem. 42, 720–724.PubMedCrossRefGoogle Scholar
  171. 171.
    Jain, R. K., Pawar, S. M., Chandrasekaran, E. V., Piskorz, C. F. & Matta, K. L. (1993): Synthesis of Gal-β-1→tFuc-α-1→4)GIcNAc-β-OR as potential acceptors for a new member of the α-1,2-L-fucosyltransferase family. Bioorg. Med. Chem. Lett. 3, 1333–1338.CrossRefGoogle Scholar
  172. 172.
    Jarkowsky, Z., Marcus, D. M. & Grollman, E. F. (1970): Fucosyltransferases found in human milk. Product of the Lewis blood group gene. Biochemistry 9, 1123–1128.CrossRefGoogle Scholar
  173. 173.
    Jeannet, M., Schapira, M. & Magnin, C. (1974): Mise en évidence d’anticorps lymphocytotoxiques dirigés contre les antigènes A et B et contre des antigènes d’histocompatibilité non HL-A. Schweiz. Med. Wochenschr. 104, 152.PubMedGoogle Scholar
  174. 174.
    Johnson, P. H., Donald, A. S. R., Clarke, J. L. & Watkins, W. M. (1995): Purification, properties and possible gene assignment of an α1, 3-fucosyltransferase expressed in human liver. Glycoconj. J. 12, 879–893.PubMedCrossRefGoogle Scholar
  175. 175.
    Johnson, P. H., Donald, A. S. R., Feeney, J. & Watkins, W. M. (1992): Reassessment of the acceptor specificity and general properties of the Lewis blood-group gene associated α-3/4-fucosyltransferase purified from human milk. Glycoconj. J. 9, 251–264.PubMedCrossRefGoogle Scholar
  176. 176.
    Johnson, P. H., Donald, A. S. R. & Watkins, W. M. (1993): Purification and properties of the α-3/4-L-fucosyltransferase released into the culture medium during the growth of the human A431 epidermoid carcinoma cell line. Glycoconj. J. 10, 152–164.PubMedCrossRefGoogle Scholar
  177. 177.
    Johnson, P. H., Watkins, W. M. & Donald, A. S. R. (1987). Further purification of the Le gene associated alpha-L-fucosyltransferase from human milk. Proceedings of the 9th International Symposium on Glycoconjugates, Lille, E 107.Google Scholar
  178. 178.
    Johnson, P. H., Yates, A. D. & Watkins, W. M. (1981): Human salivary fucosyltransferases: evidence for two distinct α-3-L-fucosyltransferase activities one of which is associated with the Lewis blood group Le gene. Biochem. Biophys. Res. Commun. 100, 1611–1618.PubMedCrossRefGoogle Scholar
  179. 179.
    Jordal, K. (1956): The Lewis blood groups in children. Acta Pathol. Microbiol. Scand. 39, 399–406.PubMedGoogle Scholar
  180. 180.
    Judd, W. J., Steiner, E. A., Friedman, B. A. & Oberman, H. A. (1978): Anti-Lea as an autoantibody in the serum of a Le(a-b+) individual. Transfusion 18, 436–440.PubMedCrossRefGoogle Scholar
  181. 181.
    Kaizu, T., Levery, S. B., Nudelman, E., Stenkamp, R. E. & Hakomori, S. I. (1986): Novel fucolipids of human adenocarcinoma: monoclonal antibody specific for trifucosyl Ley (IH3FucV3FucVI2FucnLc6) and a possible three-dimensional epitope structure. J. Biol. Chem. 261, 11254–11258.PubMedGoogle Scholar
  182. 182.
    Kaladas, P. M., Kabat, E. A., Shibata, S. & Goldstein, I. J. (1983): Immunochemical studies on the binding specificity of the blood group Leb specific lectin Griffonia simplicifolia IV. Arch. Biochem. Biophys. 223, 309–318.PubMedCrossRefGoogle Scholar
  183. 183.
    Kameyama, A., Ishida, H., Kiso, M. & Hasegawa, A. (1991): Synthetic studies on sialoglycoconjugates. 22. Total synthesis of tumor-associated ganglioside, sialyl Lewis X. J. Carbohydr. Chem. 10, 549–560.CrossRefGoogle Scholar
  184. 184.
    Kaneko, M., Kudo, T., Iwasaki, H., Ikehara, Y., Nishihara, S., Nakagawa, S., Sasaki, K., Shiina, T., Inoko, H., Saitou, N. & Narimatsu, H. (1999): α1,3-fucoslytransferase IX (Fuc-TIX) is very highly conserved between human and mouse; molecular cloning, characterization and tissue distribution of human Fuc-TIX. FEBS Lett. 452, 237–242.PubMedCrossRefGoogle Scholar
  185. 185.
    Kaneko, T., Iba, Y., Zenita, K., Shigeta, K., Nakano, K., Itoh, W., Kurosawa, Y., Kannagi, R. & Yasukawa, K. (1993): Preparation of mouse-human chimeric antibody to an embryonic carbohydrate antigen, Lewis Y. J. Biochem. 113, 114–117.PubMedGoogle Scholar
  186. 186.
    Kannagi, R., Levery, S. B. & Hakomori, S. I. (1985): Lea-active heptaglycosylceramide, a hybrid of type 1 and type 2 chain, and the pattern of glycolipids with Lea, Leb, X (Lex), and Y(Ley) determinants in human blood cell membranes (ghosts). Evidence that type 2 chain can elongate repetively but type 1 chain cannot. J. Biol. Chem. 260, 6410–6415.PubMedGoogle Scholar
  187. 187.
    Kannagi, R., Nudelman, E., Levery, S. B. & Hakomori, S. I. (1982): A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen, SSEA-1. J. Biol. Chem. 257, 14865–14874.PubMedGoogle Scholar
  188. 188.
    Karlsson, K. A. & Larson, G. (1981): Molecular characterization of cell surface antigens of fetal tissue. Detailed analysis of glycosphingolipids of meconium of a human O Le(a-b+) secretor. J. Biol. Chem. 256, 3512–3524.PubMedGoogle Scholar
  189. 189.
    Kerde, C., Brunk, R., Fünfhausen, G. & Prokop, O. (1960): Über die Herstellung von Anti-Lewis-Seren an Capra hircus. Z. Immun.-Forsch. 119, 462–468.Google Scholar
  190. 190.
    Kerr, M. A. & Stocks, S. C. (1992): The role of CD15-(Lex)-related carbohydrates in neutrophil adhesion. Histochem. J. 24, 811–826.PubMedCrossRefGoogle Scholar
  191. 191.
    Kltagawa, K, Nakada, H., Fukui, S., Funakoshi, I., Kawasaki, T., Yamashina, I., Täte, S. & Inagaki, F. (1991): Novel oligosaccharides with the sialyl-Lea structure in human milk. Biochemistry 30, 2869–2876.CrossRefGoogle Scholar
  192. 192.
    Kltagawa, H., Nakada, H., Fukui, S., Kawasaki, T. & Yamashina, I. (1991): Characterization of mucin-type oligosaccharides with the sialyl-Lea structure from human colorectal adenocarcinoma cells. Biochem. Biophys. Res. Commun. 178, 1429–1436.CrossRefGoogle Scholar
  193. 193.
    Kitagawa, H., Nakada, H., Kurosaka, A., Hiraiwa, N., Numata, Y., Fukui, S., Funakoshi, I., Kawasaki, T., Yamashina, I., Shimada, I. & Inagaki, F. (1989): Three novel oligosaccharides with the sialyl-Lea structure in human milk: isolation by immunoaffinity chromatography. Biochemistry 28, 8891–8897.PubMedCrossRefGoogle Scholar
  194. 194.
    Kitagawa, H., Nakada, H., Numata, Y., Kurosaka, A., Fukui, S., Funakoshi, I., Kawasaki, T., Shimada, I., Inagaki, F. & Yamashina, I. (1990): Occurrence of tetra-and pentasaccharides with the sialyl-Lea structure in human milk. J. Biol. Chem. 265, 4859–4862.PubMedGoogle Scholar
  195. 195.
    Kitagawa, H., Nakada, H., Numata, Y., Kurosaka, A., Fukui, S., Funakoshi, I., Kawasaki, T. & Yamashina, I. (1988): A monoclonal antibody that recognizes sialyl-Lea oligosaccharide, but is distinct from NS 19-9 as to epitope recognition. J. Biochem. 104, 817–821.PubMedGoogle Scholar
  196. 196.
    Klug, T. L., Ledonne, N. C., Greber, T. F. & Zurawski, V. R. (1988): Purification and composition of a novel gastrointestinal tumor-associated glycoprotein expressing sialylated lacto-N-fucopentaose-ll (CA 19-9). Cancer Res. 48, 1505–1511.PubMedGoogle Scholar
  197. 197.
    Knibbs, R. N., Craig, R. A., Maly, P., Smith, P. L., Wolber, F. M., Faulkner, N. E., Lowe, J. B. & Stoolman, L. M. (1998): α(1,3)-fucosyltransferase Vll-dependent synthesis of P-and E-selectin ligands on cultured T lymphoblasts. J. Immunol. 161, 6305–6315.PubMedGoogle Scholar
  198. 198.
    Ko, A. I., Dräger, U. C. & Harn, D. A. (1990): A Schistosoma mansoni epitope recognized by a protective monoclonal antibody is identical to the stage-specific embryonic antigen 1. Proc. Natl. Acad. Sci. USA 87, 4159–4163.PubMedCrossRefGoogle Scholar
  199. 199.
    Kobata, A. (1977): Milk glycoproteins and oligosaccharides. In: The Glycoconjugates (M. I. Horowitz and W. Pigman, eds.). Vol. 1, pp. 423–440.Google Scholar
  200. 200.
    Kobata, A. & Ginsburg, V. (1970): Uridine diphosphate-N-acetyl-D-galactosamineiD-galactose α-3-N-acetyl-D-galactosaminyltransferase, a product of the gene that determines blood type A in man. J. Biol. Chem. 245, 1484–1490.PubMedGoogle Scholar
  201. 201.
    Koda, Y., Klmura, H. & Mekada, E. (1993): Analysis of Lewis fucosyltransferase genes from the human gastric mucosa of Lewis-positive and Lewis-negative individuals. Blood 82, 2915–2919.PubMedGoogle Scholar
  202. 202.
    Koprowski, H., Herlyn, M., Steplewski, Z. & Sears, H. (1981): Specific antigen in serum of patients with colon carcinoma. Science 212, 53–55.PubMedCrossRefGoogle Scholar
  203. 203.
    Koprowski, H., Steplewski, Z., Mitchell, K., Herlyn, M., Herlyn, D. & Fuhrer, J. P. (1979): Colorectal carcinoma antigens detected by hybidoma antibodies. Somat. Cell Genet 5, 957–972.PubMedCrossRefGoogle Scholar
  204. 204.
    Kornstad, I. (1969): Anti-Leb in the serum of Le(a+b-) and Le(a-b-) persons: absorption studies with erythrocytes of different ABO and Lewis phenotypes. Vox Sang. 16, 124–129.PubMedCrossRefGoogle Scholar
  205. 205.
    Koszdin, K. L. & Bowen, B. R. (1992): The cloning and expression of a human α-1,3 fucosyltransferase capable of forming the E-selectin ligand. Biochem. Biophys. Res. Commun. 187, 152–157.PubMedCrossRefGoogle Scholar
  206. 206.
    Kuijpers, T. W. (1993): Terminal glycosyltransferase activity — a selective role in cell adhesion. Blood 81, 873–882.PubMedGoogle Scholar
  207. 207.
    Kukowska-Latallo, J. F., Larsen, R. D., Nair, R. P. & Lowe, J. B. (1990): A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group α(1,3/1,4) fucosyltransferase. Genes Dev. 4, 1288–1303.PubMedCrossRefGoogle Scholar
  208. 208.
    Kumar, R., Potvin, B., Müller, W. A. & Stanley, P. (1991): Cloning of a human α(1,3)-f ucosyl-transferase gene that encodes ELFT but does not confer ELAM-1 recognition on Chinese hamster ovary cell transfectants. J. Biol. Chem. 266, 21777–21783.PubMedGoogle Scholar
  209. 209.
    Kunzendorf, U., Kruqerkrasagakes, S., Netter, M., Hock, H., Walz, G. & Diamantstein, T. (1994): A sialyl-Le(X)-negative melanoma cell line binds to E selectin but not to P selectin. Cancer Res. 54, 1109–1112.PubMedGoogle Scholar
  210. 210.
    Lamblin, G., Biersman, A., Klein, A., Roussel, P., VanHalbeek, H. & Vliegenthart, J. F. G. (1984): Primary structure determination of five sialylated oligosaccharides derived from bronchial mucus glycoproteins of patients suffering from cystic fibrosis. The occurrence of the NeuAcα(2→3)Galβ(1 →4)[Fucα(1 →3)]GlcNAcβ(1 →*) structural element revealed by 500-MHz 1H NMR spectroscopy. J. Biol. Chem. 259, 9051–9058.PubMedGoogle Scholar
  211. 211.
    Langkilde, N. C., Wolf, H., Meldgard, P. & Orntoft, T. F. (1991): Frequency and mechanism of Lewis antigen expression in human urinary bladder and colon carcinoma patients. Brit. J. Cancer 63, 583–586.PubMedCrossRefGoogle Scholar
  212. 212.
    Lawler, S. D. & Marshall, R. (1961): Lewis and secretor characters in infancy. Vox Sang. 6, 541–554.PubMedCrossRefGoogle Scholar
  213. 213.
    Le Pendu, J., Fredman, P., Richter, N. D., Magnani, J. L., Willingham, M. C., Pastan, I., Oriol, R. & Ginsburg, V. (1985): Monoclonal antibody 101 that precipitates the glycoprotein receptor for epidermal growth factor is directed against the Y antigen, not the H type 1 antigen. Carbohydr. Res. 141, 347–349.PubMedCrossRefGoogle Scholar
  214. 214.
    Le Pendu, J., Lemieux, R. U., Dalix, A. M., Lambert, F. & Oriol, R. (1983): Compétition between ABO and Le gene specified enzymes. I. A Lewis related difference in the amount of A antigen in saliva of A1, and A2 secretors. Vox Sang. 45, 349–358.PubMedCrossRefGoogle Scholar
  215. 215.
    Le Pendu, J., Lemieux, R. U. & Oriol, R. (1982): Purification of anti-Lec antibodies with specificity for βdGal(1→3)βdGIcNAcO-using a synthetic immunoadsorbent. Vox Sang 43, 188–195.PubMedCrossRefGoogle Scholar
  216. 216.
    Le Pendu, J., Oriol, R., Lambert, F., Dalix, A. M. & Lemieux, R. U. (1983): Competition between ABO and Le gene specified enzymes. II. Quantitative analysis of A and B antigens in saliva of ABH nonsecretors. Vox Sang. 45, 421–425.PubMedCrossRefGoogle Scholar
  217. 217.
    Legault, D. J., Kelly, R. J., Natsuka, Y. & Lowe, J. B. (1995): Human α(1,3/1,4)-fucosyl-transferases discriminate between different oligosaccharide acceptor substrates through a discrete peptide fragment. J. Biol. Chem. 270, 20987–20996.PubMedCrossRefGoogle Scholar
  218. 218.
    Lemieux, R. U. (1978): Human blood groups and carbohydrate chemistry. Chem. Soc. Rev. 7, 423–452.CrossRefGoogle Scholar
  219. 219.
    Lemieux, R. U., Baker, D. A., Weinstein, W. M. & Switzer, C. M. (1981): Artificial antigens. Antibody preparations for the localization of Lewis determinants in tissues. Biochemistry 20, 199–205.PubMedCrossRefGoogle Scholar
  220. 220.
    Lemieux, R. U., Bundle, D. R. & Baker, D. A. (1975): The properties of a “synthetic” antigen related to the human blood-group Lewis a. J. Amer. Chem. Soc. 97, 4076–4083.CrossRefGoogle Scholar
  221. 221.
    Lemieux, R. U. & Driguez, H. J. (1975): The chemical synthesis of 2-acetamido-2-deoxy-4-O-(α-L-fucopyranosyl)-3-O-(β-D-galactopyranosyl)-D-glucose. The Lewis a blood group antigenic determinant J. Amer. Chem. Soc. 97, 4063–4068.CrossRefGoogle Scholar
  222. 222.
    Lemieux, R. U., Hindsgaul, O., Bird, P., Narasimhan, S. & Young, W. W. (1988): The binding of the Lewis-a human blood group determinant by two hybridoma monoclonal anti-Lea antibodies. Carbohydr. Res. 178, 293–305.PubMedCrossRefGoogle Scholar
  223. 223.
    Levery, S. B., Nudelman, E. D., Andersen, N. H. & Hakomori, S. I. (1986): 1H-N.M.R. analysis of glycolipids possessing mono-and multi-meric X and Y haptens: characterization of two novel extended Y structures from human adenocarcinoma. Carbohydr. Res. 151, 311–328.PubMedCrossRefGoogle Scholar
  224. 224.
    Levine, P. & Celano, M. (1960): The antigenicity of Lewis (Lea) substance in saliva coated on to tanned red cells. Vox Sang. 5, 53–61.PubMedCrossRefGoogle Scholar
  225. 225.
    Ley, K., Bullard, D. C., Arbones, M. L., Bosse, R., Vestweber, D., Tedder, T. F. & Beaudet, A. L. (1995): Sequential contribution of L-and P-selectin to leukocyte rolling in vivo. J. Exp. Med. 181, 669–675.PubMedCrossRefGoogle Scholar
  226. 226.
    Lin, M. & Shieh, S. H. (1994): Postnatal development of red cell Lea and Leb antigens in Chinese infants. Vox Sang. 66, 137–140.PubMedCrossRefGoogle Scholar
  227. 227.
    Lindström, K., Breimer, M. E., Jovall, P. A., Lanne, B., Pimlott, W. & Samuelsson, B. E. (1992): Non-acid glycosphingolipid expression in plasma of an A, Le(a-b+) secretor human individual: identification of an ALeb heptaglycosylceramide as major blood group component. J. Biochem. 111, 337–345.PubMedGoogle Scholar
  228. 228.
    Lloyd, K. O. & Kabat, E. A. (1968): Immunochemical studies on blood groups. XLI. Proposed structures for the carbohydrate portions of blood group A, B, H, Lewisa, and Lewisb substances. Proc. Natl. Acad. Sci. USA 61, 1470–1477.PubMedCrossRefGoogle Scholar
  229. 229.
    Lloyd, K. O., Larson, G., Strömberg, N., Thurin, J. & Karlsson, K. A. (1983): Mouse monoclonal antobody F-3 recognizes the difucosyl type-2 blood group structure. Immunogenetics 17, 537–541.PubMedCrossRefGoogle Scholar
  230. 230.
    Lodge, T. W., Andersen, J. & Gold, E. R. (1965): Observations on antibodies reacting with adult and cold Le(a-b-) cells, with Oh Le(a-b-) cells and a soluble antigen present in certain salivas. Vox Sang. 10, 73–81.PubMedCrossRefGoogle Scholar
  231. 231.
    Lowe, J. B., Kukowska-Latallo, J. F., Nair, R. P., Larsen, R. D., Marks, R. M., Macher, B. A., Kelly, R. J. & Ernst, L. K. (1991): Molecular cloning of a human fucosyltransferase gene that determines expression of the Lewis x and VIM-2 epitopes but not ELAM-1 dependent cell adhesion. J. Biol. Chem. 266, 17467–17477.PubMedGoogle Scholar
  232. 232.
    Lundblad, A. (1977): Urinary glycoproteins, glycopeptides, and oligosaccharides. In: The Glycoconjugates (M. I. Horowitz and W. Pigman, eds.). Vol. 1, pp. 441–458.Google Scholar
  233. 233.
    Luscinskas, F. W., Ding, H. & Lichtman, A. H. (1995): P-selectin and vascular cell adhesion molecule 1 mediate rolling and arrest, respectively, of CD4+ T lymphocytes on tumor necrosis factor alpha-activated vascular endothelium under flow. J. Exp. Med. 181, 1179–1186.PubMedCrossRefGoogle Scholar
  234. 234.
    Macher, B. A., Buehler, J., Scudder, P., Knapp, W. & Feizi, T. (1988): A novel carbohydrate, differentiation antigen on fucogangliosides of human myeloid cells recognized by monoclonal antibody VIM-2. J. Biol. Chem. 263, 10186–10191.PubMedGoogle Scholar
  235. 235.
    Macher, B. A., Holmes, E. H., Swiedler, S. J., Stults, C. L. & Srnka, C. A. (1991): Human α 1-3 fucosyltransferases. Glycobiology 1, 577–584.PubMedCrossRefGoogle Scholar
  236. 236.
    Magnani, J. L., Nilsson, B., Brockhaus, M., Zopf, D., Steplewski, Z., Koprowski, H. & Ginsburg, V. (1982): A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J. Biol. Chem. 257, 14365–14369.PubMedGoogle Scholar
  237. 237.
    Magnani, J. L., Steplewski, Z., Koprowski, H. & Ginsburg, V. (1983): The gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients is a mucin. Cancer Res. 43, 5489–5492.PubMedGoogle Scholar
  238. 238.
    Majuri, M. L., Niemelä, R., Tiisala, S., Renkonen, O. & Renkonen, R. (1995): Expression and function of α2,3-sialyl-and α1,3/1,4-fucosyltransferases in colon adenocarcinoma cell lines: role in synthesis of E-selectin counter-receptors. Int. J. Cancer 63, 551–559.PubMedCrossRefGoogle Scholar
  239. 239.
    Mäkelä, O. & Mäkelä, P. (1956): Leb antigen. Studies on its occurrence in red cells, plasma, and saliva. Ann. Med. Exp. Biol. Fenn. 34, 157–162.PubMedGoogle Scholar
  240. 240.
    Makni, S., Dalix, A. M., Caillard, T., Compagnon, B., Le Pendu, J., Ayed, K. & Oriol, R. (1987): Discordance between red cell and saliva Lewis phenotypes in patients with hydatid cysts. Exp. Clin. Immunogenet. 4, 136–143.PubMedGoogle Scholar
  241. 241.
    Maly, P., Thall, A. D., Petryniak, B., Rogers, G. E., Smith, P. L., Marks, R. M., Kelly, R. J., Gersten, K. M., Cheng, G. Y., Saunders, T. L., Camper, S. A., Camphausen, R. T., Sullivan, F. X., Isogai, Y., Hindsgaul, O., Von Andrian, U. H. & Lowe, J. B. (1996): The a(1,3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell 86, 643–653.PubMedCrossRefGoogle Scholar
  242. 242.
    Mandel, U., Orntoft, T. F., Holmes, E. H., Sorensen, H., Clausen, H., Hakomori, S. I. & Dabelsteen, E. (1991): Lewis blood group antigens in salivary glands and stratified epithelium lack of regulation of Lewis antigen expression in ductal and buccal mucosal lining epithelia. Vox Sang. 61, 205–214.PubMedCrossRefGoogle Scholar
  243. 243.
    Marcus, D. M., Bastani, A., Rosenfield, R. E. & Grollman, A. P. (1967): Studies on blood group substances. II. Hemagglutinating properties of caprine antisera to human Lea and Leb blood group substances. Transfusion 7, 277–280.PubMedCrossRefGoogle Scholar
  244. 244.
    Marcus, D. M. & Cass, L. E. (1969): Glycosphingolipids with Lewis blood group activity: uptake by human erythrocytes. Science 164, 553–555.PubMedCrossRefGoogle Scholar
  245. 245.
    Marcus, D. M. & Grollman, A. P. (1966): Studies of blood group substances. I. Caprine precipitating antisera to human Lea and Leb blood group substances. J. Immunol. 97, 867–875.PubMedGoogle Scholar
  246. 246.
    Martin, S. L., Edbrooke, M. R., Hodgman, T. C., Van Den Eunden, D. H. & Bird, M. I. (1997): Lewis X biosynthesis in Helicobacter pylori. Molecular cloning of an α(1,3)-fucosyltransferase gene. J. Biol. Chem. 272, 21349–21356.PubMedCrossRefGoogle Scholar
  247. 247.
    Mayr, W. R. & Mayr, D. (1974): A lymphocytotoxic antibody associated with ABO blood group and ABH secretor status. J. Immunogenet. 1, 43–48.Google Scholar
  248. 248.
    Mccurley, R. S., Recinos, A., Olsen, A. S., Gingrich, J. C., Szczepaniak, D., Cameron, H. S., Krauss, R. & Weston, B. W. (1995): Physical maps of human α(1,3)fucosyltransferase genes FUT3-FUT6 on chromosomes 19p13.3 and 11q21. Genomics 26, 142–146.PubMedCrossRefGoogle Scholar
  249. 249.
    Mcever, R. P., Mooore, K. L & Cummings, R. D. (1995): Leukocyte trafficking mediated by selectin-carbohydrate interactions. J. Biol. Chem. 270, 11025–11028.PubMedCrossRefGoogle Scholar
  250. 250.
    Mckibbin, J. M., Spencer, W. A., Smith, E. L., Mansson, J. E., Karlsson, K. A., Samuelsson, B. E., Li, Y. T. & Li, S. C. (1982): Lewis blood group fucolipids and their isomers from human and canine intestine. J. Biol. Chem. 257, 755–760.PubMedGoogle Scholar
  251. 251.
    Melo, N. S., Nimtz, M., Conradt, H. S., Fevereiro, P. S. & Costa, J. (1997): Identification of the human Lewisa carbohydrate motif in a secretory peroxidase from a plant cell suspension culture (Vaccinium myrtillus L.). FEBS Lett. 415, 186–191.PubMedCrossRefGoogle Scholar
  252. 252.
    Messeter, L., Brodin, T., Chester, M. A., Karlsson, K. A., Zopf, D. & Lundblad, A. (1984): Immunochemical characterization of a monoclonal anti-Leb blood grouping reagent. Vox Sang. 46, 66–74.PubMedCrossRefGoogle Scholar
  253. 253.
    Miller-Podraza, H., Abul Milh, M., Teneberg, S. & Karlsson, K. A. (1997): Binding of Helicobacter pylori to sialic acid-containing glycolipids of various origins separated on thin-layer chromatograms. Infect. Immun. 65, 2480–2482.PubMedGoogle Scholar
  254. 254.
    Miller-Podraza, H., Milh, M. A., Bergström, J. & Karlsson, K. A. (1996): Recognition of glycoconjugates by Helicobacter pylori: an apparently high-affinity binding of human polyglycosylceramides, a second sialic acid-based specificity. Glycoconj. J. 13, 453–460.PubMedCrossRefGoogle Scholar
  255. 255.
    Mitsakos, A., Hanisch, F. G. & Uhlenbruck, G. (1988): Biosynthesis of the cancer-associated sialyl-Le” determinant in human amniotic fluid. Biol. Chem. Hoppe-Seyler 369, 661–665.PubMedCrossRefGoogle Scholar
  256. 256.
    Mollicone, R., Candelier, J. J., Mennesson, B., Couillin, P., Venot, A. P. & Oriol, R. (1992): Five specificity patterns of (1→3)-α-L-fucosyltransferase activity defined by use of synthetic oligosaccharide acceptors. Differential expression of the enzymes during human embryonic development and in adult tissues. Carbohydr. Res. 228, 265–276.PubMedCrossRefGoogle Scholar
  257. 257.
    Mollicone, R., Gibaud, A., Francois, A., Ratcliffe, M. & Oriol, R. (1990): Acceptor specificity and tissue distribution of three human α-3-fucosyltransferases. Eur. J. Biochem. 191, 169–176.PubMedCrossRefGoogle Scholar
  258. 259.
    Mollicone, R., Requigne, I., Fletcher, A., Aziz, A., Rustam, M., Weston, B. W., Kelly, R. J., Lowe, J. B. & Oriol, R. (1994): Molecular basis for plasma α(1,3)-fucosyltransferase gene deficiency (FUT6). J. Biol. Chem. 269, 12662–12671.PubMedGoogle Scholar
  259. 260.
    Mollicone, R., Reguigne, I., Kelly, R. J., Fletcher, A., Watt, J., Chatfield, S., Aziz, A., Cameron, H. S., Weston, B. W., Lowe, J. B. & Oriol, R. (1994): Molecular basis for Lewis α(1,3/1,4)-fucosyltransferase gene deficiency (FUT3) found in Lewis-negative Indonesian pedigrees. J. Biol. Chem. 269, 20987–20994.PubMedGoogle Scholar
  260. 261.
    Mollison, P. L., Engelfriet, P. & Contreras, M. (1992): Blood Transfusion in Clinical Medicine. 9th edn., Blackwell, Oxford, UK.Google Scholar
  261. 262.
    Monteiro, M. A., Chan, K. H. N., Rasko, D. A., Taylor, D. E., Zheng, P. Y., Appelmelk, B. J., Wirth, H. P., Yang, M. Q., Blaser, M. J., Hynes, S. O., Moran, A. P. & Perry, M. B. (1998): Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides. J. Biol. Chem. 273, 11533–11543.PubMedCrossRefGoogle Scholar
  262. 263.
    Moor-Jankowski, J., Wiener, A. S. & Rogers, C. M. (1964): Human blood group factors in non-human primates. Nature 202, 663–665.PubMedCrossRefGoogle Scholar
  263. 264.
    Mourant, A. E. (1946): A ‘new’ human blood group antigen of frequent occurrence. Nature 158, 237–238.PubMedCrossRefGoogle Scholar
  264. 265.
    Mourant, A. E., Kopec, A. C. & Domaniewska-Sobczak, K. (1976): The distribution of the human blood groups and other polymorphisms. 2nd edn. Oxford University Press, London.Google Scholar
  265. 266.
    Mulligan, M. S., Lowe, J. B., Larsen, R. D., Paulson, J., Zheng, Z. L., Defrees, S., Maemura, K., Fukuda, M. & Ward, P. A. (1993): Protective effects of sialylated oligosaccharides in immune complex-induced acute lung injury. J. Exp. Med. 178, 623–631.PubMedCrossRefGoogle Scholar
  266. 267.
    Mulligan, M. S., Paulson, J. C., De Frees, S., Zheng, Z. L., Lowe, J. B. & Ward, P. A. (1993): Protective effects of oligosaccharides in P-selectin-dependent lung injury. Nature 364, 149–151.PubMedCrossRefGoogle Scholar
  267. 268.
    Munro, J. R. & Schachter, H. (1973): The presence of two GDP-L-fucose:glycoprotein fucosyltransferases in human serum. Arch. Biochem. Biophys. 156, 534–542.PubMedCrossRefGoogle Scholar
  268. 269.
    Muramatsu, H., Kamada, Y. & Muramatsu, T. (1986): Purification and properties of N-acetylglucosaminide α1→3 fucosyltransferase from embryonal carcinoma cells. Eur. J. Biochem. 157, 71–75.PubMedCrossRefGoogle Scholar
  269. 270.
    MÜthing, J., Spanbroek, R., Peter-Katalinic, J., Hanisch, F. G., Hanski, C., Hasegawa, A., Unland, F., Lehmann, J., Tschesche, H. & Egge, H. (1996): Isolation and structural characterization of fucosylated gangliosides with linear poly-N-acetyllactosaminyl chains from human granulocytes. Glycobiology 6, 147–156.PubMedCrossRefGoogle Scholar
  270. 271.
    Nakamura, J. I., Mogi, A., Asao, T., Nagamachi, Y. & Yazawa, S. (1997): Evidence that the aberrant α1 →2 fucosyltransferase found in colorectal carcinoma may be encoded by Fuc-TIII (Le) gene. Anticancer Res. 17, 4563–4569.PubMedGoogle Scholar
  271. 272.
    Natsuka, S., Gersten, K. M., Zenita, K., Kannagi, R. & Lowe, J. B. (1994): Molecular cloning of a cDNA encoding a novel human leukocyte α-1,3-fucosyltransferase capable of synthesizing the sialyl Lewis x determinant. J. Biol. Chem. 269, 16789–16794.PubMedGoogle Scholar
  272. 273.
    Nguyen, A. T., Holmes, E. H., Whitaker, J. M., Ho, S., Shetterly, S. & Macher, B. A. (1998): Human alpha 1,3/4-fucosyltransferases. I. Identification of amino acids involved in acceptor Substrate binding by site-directed mutagenesis. J. Biol. Chem. 273, 25244–25249.PubMedCrossRefGoogle Scholar
  273. 274.
    Nicholas, J. W., Jenkins, W. J. & Marsh, W. L (1957): Human blood chimaeras. A study of surviving twins. Brit. Med. J. i, 1458–1460.CrossRefGoogle Scholar
  274. 275.
    Nielsen, L. S., Eiberg, H. & Mohr, J. (1983): Another case of a lymphoytotoxic antibody with blood group A1 Leb and A Led associated specificity. Tissue Antigens 21, 177–183.CrossRefGoogle Scholar
  275. 276.
    Nilsson, M. & Norberg, T. (1988): Synthesis of a dimeric Lewis X hexasaccharide derivative corresponding to a tumor-associated glycolipid. Carbohydr. Res. 183, 71–82.PubMedCrossRefGoogle Scholar
  276. 277.
    Nlshihara, S., Hlraga, T., Ikehara, Y., Iwasaki, H., Kudo, T., Yazawa, S., Morozumi, K., Suda, Y. & Narimatsu, H. (1999): Molecular behavior of mutant Lewis enzymes in vivo. Glycobiology 4, 373–382.CrossRefGoogle Scholar
  277. 278.
    Nlshihara, S., Narimatsu, H., Iwasaki, H., Yazawa, S., Akamatsu, S., Ando, T., Seno, T. & Narimatsu, I. (1994): Molecular genetic analysis of the human Lewis histo-blood group system. J. Biol. Chem. 269, 29271–29278.Google Scholar
  278. 279.
    Nlshihara, S., Yazawa, S., Iwasaki, H., Nakazato, M., Kudo, T., Ando, T. & Narimatsu, H. (1993): α(1,3/1,4)Fucosyltransferase (FucT-lll) gene is inactivated by a single amino acid substitution in Lewis histo-blood type negative individuals. Biochem. Biophys. Res. Commun. 196, 624–631.CrossRefGoogle Scholar
  279. 280.
    Nomura, A., Stemmermann, G. N., Chyou, P. H., Kato, I., Perez-Perez, G. I. & Blaser, M. J. (1991): Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N. Engl. J. Med. 325, 1132–1136.PubMedCrossRefGoogle Scholar
  280. 281.
    Norgard, K. E., Moore, K. L., Diaz, S., Stults, N. L., Ushiyama, S., Mcever, R. P., Cummings, R. D. & Varki, A. (1993): Characterization of a specific ligand for P-selectin on myeloid cells — a minor glycoprotein with sialylated O-linked oligosaccharides. J. Biol. Chem. 268, 12764–12774.PubMedGoogle Scholar
  281. 282.
    Nudelman, E., Fukushi, Y., Levery, S. B., Higuchi, T. & Hakomori, S. I. (1986): Novel fucolipids of human adenocarcinoma: disialosyl Lea antigen (lII4FucllI6NeuAclv3NeuAcLc4) of human colonic adenocarcinoma and the monoclonal antibody (FH7) defining this structure. J. Biol. Chem. 261, 5487–5495.PubMedGoogle Scholar
  282. 283.
    Nudelman, E., Levery, S. B., Kaizu, T. & Hakomori, S. I. (1986): Novel fucolipids of human adenocarcinoma: characterization of the major Ley antigen of human adenocarcinoma as trifucosylnonaosyl Ley glycolipid (III3FucV3FucVI3FucnLc6). J. Biol. Chem. 261, 11247–11253.PubMedGoogle Scholar
  283. 284.
    Ohmori, K., Yoneda, T., Ishihara, G., Shigeta, K., Hirashima, K., Kanai, M., Itai, S., Sasaoki, T., Arii, S. & Arita, H. (1989): Sialyl SSEA-1 antigen as a carbohydrate marker of human natural killer cells and immature lymphoid cells. Blood 74, 255–261.PubMedGoogle Scholar
  284. 285.
    Oriol, R., Cartron, J. P., Cartron, J. & Mulet, C. (1980): Biosynthesis of ABH and Lewis antigens in normal and transplanted kidneys. Transplantation 29, 184–188.PubMedCrossRefGoogle Scholar
  285. 286.
    Oriol, R., Danilovs, J., Lemieux, R. U., Terasaki, P. I. & Bernoco, D. (1980): Lymphocytotoxic definition of combined ABH and Lewis antigens and their transfer from sera to lymphocytes. Hum. Immunol. 1, 195–205.PubMedCrossRefGoogle Scholar
  286. 287.
    Oriol, R., Le Pendu, J. & Mollicone, R. (1986): Genetics of ABO, H, Lewis, X, and related antigens. Vox Sang. 51, 161–171.PubMedCrossRefGoogle Scholar
  287. 288.
    0Rntoft, T. F., Holmes, E. H., Johnson, P., Hakomori, S. & Clausen, H. (1991): Differential tissue expression of the Lewis blood group antigens: enzymatic, immunohistologic, and immunochemical evidence for Lewis a and b antigen expression in Le(a-b-) individuals. Blood 77, 1389–1396.PubMedGoogle Scholar
  288. 289.
    Ørntoft, T. F., Vestergaard, E. M., Holmes, E., Jakobsen, J. S., Grunnet, N., Mortensen, M., Johnson, P., Bross, P., Gregersen, N., Skorstengaard, K., Jensen, U. B., Bolund, L & Wolf, H. (1996): Influence of Lewis α1-3/4-L-fucosyltransferase (FUT3) gene mutations on enzyme activity, erythrocyte phenotyping, and circulating tumor marker sialyl-Lewis a levels. J. Biol. Chem. 271, 32260–32268.PubMedCrossRefGoogle Scholar
  289. 290.
    Oulmouden, A., Wlerinckx, A., Petit, J. M., Costache, M., Palcic, M. M., Mollicone, R., Oriol, R. & Julien, R. (1997): Molecular cloning and expression of a bovine α(1,3)-fucosyltransferase gene homologous to a putative ancestor gene of the human FUT3-FUT5-FUT6 cluster. J. Biol. Chem. 272, 8764–8773.PubMedCrossRefGoogle Scholar
  290. 291.
    Pacuska, T. & Koscielak, J. (1974): α 1→2 Fucosyltransferase of human bone marrow. FEBS Lett. 41, 348–351.CrossRefGoogle Scholar
  291. 292.
    Pang, H., Koda, Y., Soejima, M. & Kimura, H. (1999): Significance of each of three missense mutations, G484A, G667A, and G808A, present in an inactive allele of the human Lewis gene (FUT3) for α(1,3/1,4)fucosyltransferase inactivation. Glycoconj. J. 15, 961–967.CrossRefGoogle Scholar
  292. 293.
    Pang, H., Liu, Y. H., Koda, Y., Soejima, M., Jia, J. T., Schlaphoff, T., Du Toit, E. D. & Kimura, H. (1998): Five novel missense mutations of the Lewis gene (FUT3) in African (Xhosa) and Caucasian populations in South Africa. Hum. Genet. 102, 675–680.PubMedCrossRefGoogle Scholar
  293. 294.
    Park, M. S., Oriol, R., Nakata, S., Terasaki, P. I., Ford, R. & Bernoco, D. (1979): ABH and Lewis antigens on lymphocytes: screening of pregnant women’s sera with the B-cell cytotoxicity test. Transplant. Proc. 11, 1947–1949.PubMedGoogle Scholar
  294. 295.
    Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N. & Sibley, R. K. (1991): Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J.Med. 325, 1127–1131.PubMedCrossRefGoogle Scholar
  295. 296.
    Parsonnet, J., Hansen, S., Rodriguez, L., Gelb, A. B., Warnke, R. A., Jellum, E., Orentreich, N., Vogelman, J. H. & Friedman, G. D. (1994): Helicobacter pylori infection and gastric lymphoma. N. Engl. J. Med. 330, 1267–1271.PubMedCrossRefGoogle Scholar
  296. 297.
    Pompecki, R., Shively, J. E. & Todd, C. W. (1981): Demonstration of elevated anti-Lewis antibodies in sera of cancer patients using a carcinoembryonic antigen-polyethylene glycol immunoassay. Cancer Res. 41, 1910–1915.PubMedGoogle Scholar
  297. 298.
    Potapov, M. (1976): Production of immune-anti-Lewis sera in goats. Vox Sang. 30, 211–213.PubMedCrossRefGoogle Scholar
  298. 299.
    Potapov, M. I. (1970): Dectection of the antigen of the Lewis system, characteristic of the erythrocytes of the secretory group Le(a-b-). Probl. Haematol. (Moskow) 11, 45–49.Google Scholar
  299. 300.
    Prieels, J. P., Monnom, D., Dolmans, M., Beyer, T. A. & Hill, R. L. (1981): Co-purification of the Lewis blood group N-acetylglucosaminide α1→4 fucosyltransferase and an N-acetylglucosaminide α1→3 fucosyltransferase from human milk. J. Biol. Chem. 256, 10456–10463.PubMedGoogle Scholar
  300. 301.
    Prohaska, R., Schenkel-Brunner, H. & Tuppy, H. (1978): Enzymatic synthesis of blood-group Lewis-specific glycolipids. Eur. J. Biochem. 84, 161–166.PubMedCrossRefGoogle Scholar
  301. 302.
    Race, R. R. & Sänger, R. (1975): The Lewis groups. In: Blood Groups in Man. Blackwell Scientific Publications, Oxford, pp. 323–349.Google Scholar
  302. 303.
    Rana, S. S. & Matta, K. L. (1983): A facile synthesis of 2-acetamido-2-deoxy-4-O-α-L-fucopyranosyl-S-O-β-D-galactopyranosyl-D-glucopyranose, the Lewis a blood-group antigenic determinant, and related compounds. Carbohydr. Res. 117, 101–112.CrossRefGoogle Scholar
  303. 304.
    Reguigne, I., James, M. R., Richard, C. W., Mollicone, R., Seawright, A., Lowe, J. B., Oriol, R. & Couillin, P. (1994): The gene encoding myeloid α-3-fucosyltransferase(FUT4) is located between D11S388 and D11S919 on 11q21. Cytogenet. Cell Genet. 66, 104–106.PubMedCrossRefGoogle Scholar
  304. 305.
    Reguigne-Arnould, I., Couillin, P., Mollicone, R., Fauré, S., Fletcher, A., Kelly, R. J., Lowe, J. B. & Oriol, R. (1995): Relative positions of two clusters of human α-L-fucosyltransferases in 19q (FUT1-FUT2) and 19p (FUT6-FUT3-FUT5) within the microsatellite genetic map of chromosome 19. Cytogenet. Cell Genet. 71, 158–162.PubMedCrossRefGoogle Scholar
  305. 306.
    Reguigne-Arnould, I., Wolfe, J., Hornigold, N., Fauré, S., Mollicone, R., Oriol, R. & Coullin, P. (1996): Fucosyltransferase genes are dispersed in the genome: FUT7 is located on 9q34.3 distal to D9S1830. Compt. Rend. Acad. Sci. Ser. Ill Sci. Vie 319, 783–788.Google Scholar
  306. 307.
    Rodeck, U., Herlyn, M., Leander, K., Borunghaus, P. & Koprowski, H. (1987): A mucin containing the X, Y, and H type 2 carbohydrate determinants is shed by carcinoma cells. Hybridoma 6, 389–401.PubMedCrossRefGoogle Scholar
  307. 308.
    Rohr, T. E., Smith, D. F., Zopf, D. A. & Ginsburg, V. (1980): Leb-active glycolipids in human plasma: measurement by radioimmunoassay. Arch. Biochem. Biophys. 199, 265–269.PubMedCrossRefGoogle Scholar
  308. 309.
    Rosen, S. D. & Bertozzi, C. R. (1994): The selectins and their ligands. Curr. Opin. Cell Biol. 6, 663–673.PubMedCrossRefGoogle Scholar
  309. 310.
    Saadi, A. T., Blackwell, C. C., Raza, M. W., James, V. S., Stewart, J., Elton, R. A. & Weir, D. M. (1993): Factors enhancing adherence of toxigenic Staphylococcus aureus to epithelial cells and their possible role in sudden infant death syndrome. Epidemiol. Infect. 110, 507–517.PubMedCrossRefGoogle Scholar
  310. 311.
    Saadi, A. T., Weir, D. M., Poxton, I. R., Stewart, J., Essery, S. D., Blackwell, C. C., Raza, M. W. & Busuttil, A. (1994): Isolation of an adhesin from Staphylococcus aureus that binds Lewisa blood group antigen and its relevance to sudden infant death syndrome. FEMS Immunol. Med. Microbiol. 8, 315–320.PubMedCrossRefGoogle Scholar
  311. 312.
    Sakamoto, J., Watanabe, T., Tokumaru, T., Takagi, H., Nakazato, H. & Lloyd, K. O. (1989): Expression of Lewisa, Lewisb, Lewisx, Lewisy, sialyl-Lewisa, and sialyl-Lewisx blood group antigens in human gastric carcinoma and in normal gastric tissue. Cancer Res. 49, 745–752.PubMedGoogle Scholar
  312. 313.
    Sakamoto, J., Yin, B. W. T. & Lloyd, K. O. (1984): Analysis of the expression of H, Lewis, X, Y, and precursor blood group determinants in saliva and red cells using a panel of mouse monoclonal antibodies. Mol. Immunol. 21, 1093–1098.PubMedCrossRefGoogle Scholar
  313. 314.
    Sako, D., Chang, X. J., Barone, K. M., Vachino, G., White, H. M., Shaw, G., Veldman, G. M., Bean, K. M., Ahern, T. J., Furie, B. & Et Al. (1993): Expression cloning of a functional glycoprotein ligand for P-selectin. Cell 75, 1179–1186.PubMedCrossRefGoogle Scholar
  314. 315.
    Sarnesto, A., Kohlin, T., Hindsgaul, O., Vogele, K., Blaszczyk-Thurin, M. & Thurin, J. (1992): Purification of the β-N-acetylglucosaminide α1 →3-fucosyltransferase from human serum. J. Biol. Chem. 267, 2745–2752.PubMedGoogle Scholar
  315. 316.
    Sasaki, K., Kurata, K., Funayama, K., Nagata, M., Watanabe, E., Ohta, S., Hanai, N. & Nishi, T. (1994): Expression cloning of a novel α1,3-fucosyltransferase that is involved in biosynthesis of the sialyl Lewis x carbohydrate determinants in leukocytes. J. Biol. Chem. 269, 14730–14737.PubMedGoogle Scholar
  316. 317.
    Sato, S., Ito, Y., Nukada, T., Nakahara, Y. & Ogawa, T. (1987): Total synthesis of X hapten, III3Fucα-nLc4Cer. Carbohydr. Res. 167, 197–210.PubMedCrossRefGoogle Scholar
  317. 318.
    Sato, S., Ito, Y. & Ogawa, T. (1986): Stereo-and regio-controlled, total synthesis of the Leb antigen, III4FuclV2FucLcOse4Cer. Carbohydr. Res. 155, C1–C5.PubMedCrossRefGoogle Scholar
  318. 319.
    Schenkel-Brunner, H., Chester, M. A. & Watkins, W. M. (1972): α-L-Fucosyltransferases in human serum from donors of different ABO, secretor, and Lewis blood group phenotypes. Eur. J. Blochem. 30, 269–277.CrossRefGoogle Scholar
  319. 320.
    Schenkel-Brunner, H. & Hanfland, P. (1981): Immunochemistry of the Lewis blood-group system. III. Studies on the molecular basis of the Le” property. Vox Sang. 40, 358–366.PubMedCrossRefGoogle Scholar
  320. 321.
    Scudder, P. R., Shailubhai, K., Duffin, K. L., Streeter, P. R. & Jacob, G. S. (1994): Enzymatic synthesis of a 6′-sulphated sialyl-Lewisx which is an inhibitor of L-selectin binding to peripheral addressin. Glycobiology 4, 929–932.PubMedCrossRefGoogle Scholar
  321. 322.
    Seaman, M. J., Chalmers, D. G. & Franks, D. (1968): Siedler: an antibody which reacts with A1Le(a-b+) red cells. Vox Sang. 15, 25–30.PubMedCrossRefGoogle Scholar
  322. 323.
    Shen, L., Grollman, E. F. & Ginsburg, V. (1968): An enzymatic basis for secretor status and blood group substance specificity in humans. Proc. Natl. Acad. Sci. USA 59, 224–230.PubMedCrossRefGoogle Scholar
  323. 324.
    Sherwood, A. L., Nguyen, A. T., Whitaker, J. M., Macher, B. A., Stroud, M. R. & Holmes, E. H. (1998): Human α 1,3/4-fucosyltransferases — III. A Lys/Arg residue located within the α1,3-FucT motif is required for activity but not substrate binding. J. Biol. Chem. 273, 25256–25260.PubMedCrossRefGoogle Scholar
  324. 325.
    Shibata, S., Goldstein, I. J. & Baker, D. A. (1982): Isolation and characterization of a Lewis b-active lectin from Griffonia simplicifolia seeds. J. Biol. Chem. 257, 9324–9329.PubMedGoogle Scholar
  325. 326.
    Shinoda, K., Morishita, Y., Sasaki, K., Matsuda, Y., Takahashi, I. & Nishi, T. (1997): Enzymatic characterization of human α1,3-fucosyltransferase Fuc-TVII synthesized in a B cell lymphoma cell lines. J. Biol. Chem. 272, 31992–31997.PubMedCrossRefGoogle Scholar
  326. 327.
    Shinohara, T. & Yamamoto, S. (1983): Partial characterization of blood group Lea-and Leb-active substances isolated from human urine. Agric. Biol. Chem. 47, 141–143.CrossRefGoogle Scholar
  327. 328.
    Shinohara, T., Yamamoto, S. & Iseki, S. (1977): Some immunochemical properties of Lea-and Leb-active substances in human urine. J. Immunogenet. 4, 159–165.PubMedCrossRefGoogle Scholar
  328. 329.
    Siddiqui, B., Whitehead, J. S. & Kim, Y. S. (1978): Glycosphingolipids in human colonic adenocarcinoma. J. Biol. Chem. 253, 2168–2175.PubMedGoogle Scholar
  329. 330.
    Skacel, P. O., Edwards, A. J., Harrison, C. T. & Watkins, W. M. (1991): Enzymic control of the expression of the X determinant (CD15) in human myeloid cells during maturation: the regulatory role of 6’-sialytransferase. Blood 78, 1452–1460.PubMedGoogle Scholar
  330. 331.
    Skacel, P. O. & Watkins, W. M. (1987): Fucosyltransferase expression in human platelets and leucocytes. Glycoconj. J. 4, 267–272.CrossRefGoogle Scholar
  331. 332.
    Slomiany, A. & Slomiany, B. L. (1975): Blood-group A active difucosyl glycolipid from hog gastric mucosa. Biochim. Biophys. Ada 388, 135–145.CrossRefGoogle Scholar
  332. 333.
    Slomiany, B. L., Slomiany, A. & Horowitz, M. I. (1975): Characterization of three new fucolipids from hog gastric mucosa. Eur. J. Biochem. 56, 353–358.PubMedCrossRefGoogle Scholar
  333. 334.
    Slomiany, B. L., Zdebska, E. & Slomiany, A. (1984): Structural characterization of neutral oligosaccharides of human H{sdu+}Leb+ gastric mucin. J. Biol. Chem. 259, 2863–2869.PubMedGoogle Scholar
  334. 335.
    Smith, E. L., Mckibbin, J. M., Breimer, M. E., Karlsson, K. A., Pascher, I. & Samuelsson, B. E. (1975): Identification of a novel heptaglycosylceramide with two fucose residues and a terminal hexosamine. Biochim. Biophys. Ada 398, 84–91.CrossRefGoogle Scholar
  335. 336.
    Smith, E. L., Mckibbin, J. M., Karlsson, K. A., Pascher, I., Samuelsson, B. E., Li, Y. T. & Li, S. C. (1975): Characterization of a human intestinal fucolipid with blood group Le” activity. J. Biol. Chem. 250, 6059–6064.PubMedGoogle Scholar
  336. 337.
    Smith, E. L., Mckibbin, J. M., Karlsson, L. A., Pascher & Samuelsson, B. E. (1975): Main structures of the Forssman glycolipid hapten and a Leb-like glycolipid of dog small intestine, as revealed by mass spectrometry. Difference in ceramide structure related to tissue localization. Biochim. Biophys. Ada 388, 171–179.CrossRefGoogle Scholar
  337. 338.
    Smith, P. L., Gersten, K. M., Petryniak, B., Kelly, R. J., Rogers, C., Natsuka, Y., Alford, J. A., Scheidegger, E. P., Natsuka, S. & Lowe, J. B. (1996): Expression of the α(1,3)fucosyltransferase Fuc-TVII in lymphoid aggregate high endothelial venules correlates with expression of L-selectin ligands. J. Biol. Chem. 271, 8250–8259.PubMedCrossRefGoogle Scholar
  338. 339.
    Sneath, J. S. & Sneath, P. H. A. (1955): Transformation of the Lewis groups of human red cells. Nature 156, 172.CrossRefGoogle Scholar
  339. 340.
    Sneath, J. S. & Sneath, P. H. A. (1959): Adsorption of blood-group substances from serum on to red cells. Brit. Med. Bull. 15, 154–157.PubMedGoogle Scholar
  340. 341.
    Solter, D. & Knowles (1978): Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc. Natl. Acad. Sci. USA 75, 5565–5569.PubMedCrossRefGoogle Scholar
  341. 342.
    Spitalnik, S., Cowles, J., Cox, M. T. & Blumberg, N. (1985): Detection of IgG anti-Lewisa antibodies in cord sera by kintic ELISA. Vox Sang. 48, 235–238.PubMedCrossRefGoogle Scholar
  342. 343.
    Spohr, U., Hindsgaul, O. & Lemieux, R. U. (1985): Molecular recognition. II. The binding of the Lewis b and Y human blood group determinants by the lectin IV of Griffonia simplicifolia. Can. J. Chem. 63, 2644–2652.CrossRefGoogle Scholar
  343. 344.
    Spooncer, E., Fukuda, M., Klock, J. C., Oates, J. E. & Dell, A. (1984): Isolation and characterization of polyfucosylated lactosaminoglycan from human granulocytes. J. Biol. Chem. 259, 4792–4801.PubMedGoogle Scholar
  344. 345.
    Srivatsan, J., Smith, D. F. & Cummings, R. D. (1992): The human blood fluke Schistosoma mansoni synthesizes glycoproteins containing the Lewis X antigen. J. Biol. Chem. 267, 20196–20203.PubMedGoogle Scholar
  345. 346.
    Staudacher, E. (1996): α1,3-Fucosyltransferases. Trends Glycosci. Glycotechnol. 8, 391–408.CrossRefGoogle Scholar
  346. 347.
    Staudacher, E., Dalik, T., Wawra, P., Altmann, F. & März, L (1995): Functional purification and characterization of a GDP-fucose: β-N-acetylglucosamine (Fuc to Asn linked GlcNAc) α1,3-fucosyltransferase from mung beans. Giycoconj. J. 12, 780–786.CrossRefGoogle Scholar
  347. 348.
    Steegmaier, M., Levinovitz, A., Isenmann, S., Borges, E., Lenter, M., Kocher, H. P., Kleuser, B. & Vestweber, D. (1995): The E-selectin-ligand ESL-1 is a variant of a receptor for fibroblast growth factor. Nature 373, 615–620.PubMedCrossRefGoogle Scholar
  348. 349.
    Steplewski, Z., Blaszczyk-Thurin, M., Lübeck, M., Loibner, H., Scholz, D. & Koprowski, H. (1990): Oligosaccharide Y specific monoclonal antibody and its isotype switch variants. Hybridoma 9, 201–210.PubMedCrossRefGoogle Scholar
  349. 350.
    Stigendal, L., Olsson, R., Rydberg, L. & Samuelsson, B. E. (1984): Blood group Lewis phenotype on erythrocytes and in saliva in alcoholic pancreatitis and chronic liver disease. J. Clin. Pathol. 37, 778–782.PubMedCrossRefGoogle Scholar
  350. 351.
    Stroud, M. R., Levery, S. B., Nudelman, E. D., Salyan, M. E. K., Towell, J. A., Roberts, C. E., Watanabe, M. & Hakomori, S. I. (1991): Extended type 1 chain glycosphingolipids: dimeric Lea (III4V4Fuc2Lc6) as human tumor-associated antigen. J. Biol. Chem. 266, 8439–8446.PubMedGoogle Scholar
  351. 352.
    Stroud, M. R., Levery, S. B., Salyan, M. E. K., Roberts, C. E. & Hakomori, S. (1992): Extended type-1 chain glycosphingolipid antigens. Isolation and characterization of trifucosyl-Leb antigen (III4V4VI2Fuc3Lc6). Eur. J. Biochem. 203, 577–586.PubMedCrossRefGoogle Scholar
  352. 353.
    Sturgeon, P. & Arcilla, M. B. (1970): Studies on the secretion of blood group substances. I. Observations on the red cell phenotype Le(a+b+x+). Vox Sang. 18, 301–322.CrossRefGoogle Scholar
  353. 354.
    Szulman, A. E. & Marcus, D. M. (1973): The histologic distribution of the blod group substances in man as disclosed by immunofluorescence. VI. The Lea and Leb antigens during fetal development. Lab. Invest. 28, 565–574.PubMedGoogle Scholar
  354. 355.
    Takada, A., Ohmori, K., Takahashi, N., Tsuyuoka, K., Yago, A., Zenita, K., Hasegawa, A. & Kannagi, R. (1991): Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewisa. Biochem. Biophys. Res. Commun. 179, 713–719.PubMedCrossRefGoogle Scholar
  355. 356.
    Takada, A., Ohmori, K., Yoneda, T., Tsuyuoka, K., Hasegawa, A., Kiso, M. & Kannagi, R. (1993): Contribution of carbohydrate antigens sialyl Lewis-A and sialyl Lewis-X to adhesion of human cancer cells to vascular endothelium. Cancer Res. 53, 354–361.PubMedGoogle Scholar
  356. 357.
    Taki, T., Takamatsu, M., Myoga, A., Tanaka, K., Ando, S. & Matsumoto, M. (1988): Glycolipids of metastatic tissue in liver from colon cancer: appearance of sialylated Lex and Lex lipids. J. Biochem. 103, 998–1003.PubMedGoogle Scholar
  357. 358.
    Tanaka, M., Dube, V. E. & Anderson, B. (1984): Structures of oligosaccharides cleaved by base-borohydride from an I, H, and Lea active ovarian cyst glycoprotein. Biochim. Biophys. Acta 798, 283–290.PubMedCrossRefGoogle Scholar
  358. 359.
    Taylor, R. A., Rachkewich, R. A., Gare, D. J., Falk, J. A., Shumak, K. H. & Crookston, M. C. (1974): Effect of pregnancy of the reactivity of lymphocytes with cytotoxic antisera. Transplantation 17, 142–146.PubMedGoogle Scholar
  359. 360.
    Tegoli, J., Cortez, M., Jensen, L. & Marsh, W. L. (1971): A new antibody, anti-ILebH, specific for a determinant formed by the combined action of the I, Le, Se, and H gene products. Vox Sang. 21, 397–404.CrossRefGoogle Scholar
  360. 361.
    Teneberg, S., Miller-Podraza, H., Lampert, H. C., Evans, D. J., Evans, D. G., Danielsson, D. & Karlsson, K. A. (1997): Carbohydrate binding specificity of the neutrophil-activating protein of Helicobacter pylori. J. Biol. Chem. 272, 19067–19071.PubMedCrossRefGoogle Scholar
  361. 362.
    Tetteroo, P. A. T., De Heu, H. T., Van Den Eijnden, D. H., Visser, F. J., Schoenmaker, E. & Geurts Van Kessel, A. H. (1987): A GDP-fucose:[Galβ1→4]GIcNAc α1 →3-fucosyltransferase activity is correlated with the presence of human chromosome 11 and the expression of the Lex, Ley, and sialyl-Lex antigens in human-mouse cell hybrids. J. Biol. Chem. 262, 15984–15989.PubMedGoogle Scholar
  362. 363.
    Tilley, C. A., Crookston, M. C., Brown, B. L. & Wherrett, J. R. (1975): A and B and A1Leb substances in glycosphingolipid fractions of human serum. Vox Sang. 28, 25–33.PubMedCrossRefGoogle Scholar
  363. 364.
    Tsuboi, S., Isogai, Y., Hada, N., King, J. K., Hindsgaul, O. & Fukuda, M. (1996): 6′-Sulfo sialyl Lex but not 6-sulfo sialyl Lex expressed on the cell surface supports L-selectin-mediated adhesion. J. Biol. Chem. 271, 27213–27216.PubMedCrossRefGoogle Scholar
  364. 365.
    Valli, M., Gallanti, A., Bozzaro, S. & Trinchera, M. (1998): β-1,3-galactosyltransferase and α-1,2-fucosyltransferase involved in the biosynthesis of type-1-chain carbohydrate antigens in human colon adenocarcinoma cell lines. Eur. J. Biochem. 256, 494–501.PubMedCrossRefGoogle Scholar
  365. 366.
    Van Dam, G. J., Bergwerff, A. A., Thomas-Oates, J. E., Rotmans, J. P., Kamerling, J. P., Vliegenthart, J. F. G. & Deelder, A. M. (1994): The immunologically reactive O-linked polysaccharide chains derived from circulating cathodic antigen isolated from the human blood fluke Schistosoma mansoni have Lewis” as repeating unit. Eur. J. Biochem. 225, 467–482.PubMedCrossRefGoogle Scholar
  366. 367.
    Varki, A. (1994): Selectin ligands. Proc. Natl. Acad. Sci. USA 91, 7390–7397.PubMedCrossRefGoogle Scholar
  367. 368.
    Vos, G. H. & Comley, P. (1967): Red cell and saliva studies for the evaluation of ABH and Lewis factors among the Caucasians and Aboriginal populations of Western Australia. Acta Genet. 17, 495–510.PubMedGoogle Scholar
  368. 369.
    Vos, G. H., Moores, P. P., Downing, H. J. & Mihideen, A. F. C. (1976): Haemagglutination inhibition studies for the evaluation of blood group antigens in ethanol soluble substances (ESS) obtained from human, baboon, and vervet monkey red blood cells. Transfusion 16, 42–47.PubMedCrossRefGoogle Scholar
  369. 370.
    Wagers, A. J., Lowe, J. B. & Kansas, G. S. (1996): An important role for the α 1,3 fucosyltransferase, FucT-VII, in leukocyte adhesion to E-selectin. Blood 88, 2125–2132.PubMedGoogle Scholar
  370. 371.
    Wang, J. W., Ambros, R. A., Weber, P. B. & Rosano, T. G. (1995): Fucosyltransferase and a-L-fucosidase activities and fucose levels in normal and malignant endometrial tissue. Cancer Res. 55, 3654–3658.PubMedGoogle Scholar
  371. 372.
    Wang, W. T., Lundgren, T., Lindh, F., Nilsson, B., Grönberg, G., Brown, J. P., Mentzer-Dibert, H. & Zopf, D. (1992): Isolation of two novel sialyl-Lewisx-active oligosaccharides by high-performance liquid affinity chromatography using monoclonal antibody Onc-M26. Arch. Biochem. Biophys. 292, 433–441.PubMedCrossRefGoogle Scholar
  372. 373.
    Watkins, W. M. (1972): Blood group specific substances. In: Glycoproteins: Their Composition, Structure and Function (A. Gottschalk, ed). Elsevier, Amsterdam, pp. 830–891.Google Scholar
  373. 374.
    Watkins, W. M. (1980): Biochemistry and genetics of the ABO, Lewis and P blood group systems. In: Advances in Human Genetics. Vol. 10, pp. 1–136.PubMedGoogle Scholar
  374. 375.
    Weston, B. W., Nair, R. P., Larsen, R. D. & Lowe, J. B. (1992): Isolation of a novel human α(1,3)fucosyltransferase gene and molecular comparison to the human Lewis blood group α(1,3/1,4)fucosyltransferase gene. Syntenic, homologous, nonallelic genes encoding enzymes with distinct acceptor substrate specificities. J. Biol. Chem. 267, 4152–4160.PubMedGoogle Scholar
  375. 376.
    Weston, B. W., Smith, P. L., Kelly, R. J. & Lowe, J. B. (1992): Molecular cloning of afourth member of a human α(1,3)fucosyltransferase gene family. Multiple homologous sequences that determine expression of the Lewisx, sialyl Lewisx, and difucosyl sialyl Lewis” epitopes. J. Biol. Chem. 267, 24575–24584.PubMedGoogle Scholar
  376. 377.
    Wu, J. T. & Chang, J. (1992): Chromatographic characterization of CA-19-9 molecules from cystic fibrosis and pancreatic carcinoma. J. Clin. Lab. Anal. 6, 209–215.PubMedCrossRefGoogle Scholar
  377. 378.
    Wu, J. T., Olson, J. & Walker, K. (1992): Tumor markers CA 19-9 and CA 195 are also useful markers for cystic fibrosis. J. Clin. Lab. Anal. 6, 151–161.PubMedCrossRefGoogle Scholar
  378. 379.
    Wyatt, J. I. & Dixon, M. F. (1988): Chronic gastritis — a pathogenetic approach. J. Pathol. 154, 113–124.PubMedCrossRefGoogle Scholar
  379. 380.
    Xu, X. H., Vo, L. & Macher, B. A. (1996): Structure-function analysis of human α1,3-fucosyltransferase. Amino acids involved in acceptor substrate specificity. J. Biol. Chem. 271, 8818–8823.PubMedCrossRefGoogle Scholar
  380. 381.
    Yago, K., Zenita, K., Ginya, H., Sawada, M., Ohmori, K., Okuma, M., Kannagi R. & Lowe, J. B. (1993): Expression of α(1,3)-fucosyltransferases which synthesize sialyl Lex and sialyl Lea, the carbohydrate ligands for E-selectin and P-selectin, in human malignant cell lines. Cancer Res. 53, 5559–5565.PubMedGoogle Scholar
  381. 382.
    Yago, T., Tsukuda, M., Yamazaki, H., Nishi, T., Amano, T. & Minami, M. (1995): Analysis of an initial step of T cell adhesion to endothelial monolayers under flow conditions. J. Immunol. 154, 1216–1222.PubMedGoogle Scholar
  382. 383.
    Yamamoto, S. (1982): Inhibitory activities of substances present in plant seeds and fruits against anti-Lewis agglutinins. J. Immunogenet. 9, 137–141.PubMedCrossRefGoogle Scholar
  383. 384.
    Yazawa, S. & Furukawa, K. (1980): α-L-Fucosyltransferases related to biosynthesis of blood group substances in human saliva. J. Immunogenet. 7, 137–148.PubMedCrossRefGoogle Scholar
  384. 385.
    Yazawa, S., Madiyalakan, R., Izawa, H., Asao, T., Furukawa, K. & Matta, K. L. (1988): Cancer-associated elevation of α(1 → 3)-L-fucosyltransferase activity in human serum. Cancer 62, 516–520.PubMedCrossRefGoogle Scholar
  385. 386.
    Yazawa, S., Nishihara, S., Iwasaki, H., Asao, T., Nagamachi, Y., Matta, K. L. & Narimatsu, H. (1995): Genetic and enzymatic evidence for Lewis enzyme expression in Lewis-negative cancer patients. Cancer Res. 55, 1473–1478.PubMedGoogle Scholar
  386. 387.
    Young, W. W., Johnson, H. S., Tamura, Y., Karlsson, K. A., Larson, G., Parker, J. M. R., Khare, D. P., Spohr, U., Baker, D. A., Hindsgaul, O. & Lemieux, R. U. (1983): Characterization of monoclonal antibodies specific for the Lewisa human blood group determinant. J. Biol. Chem. 258, 4890–4894.PubMedGoogle Scholar
  387. 388.
    Yuen, C. T., Bezouska, K., O’brien, J., Stoll, M., Lemoine, R., Lubineau, A., Kiso, M., Hasegawa, A., Bockovich, N. J., Nicolaou, K. C. & Feizi, T. (1994): Sulfated blood group Lewisa.A superior oligosaccharide ligand for human E-selectin. J. Biol. Chem. 269, 1595–1598.PubMedGoogle Scholar
  388. 389.
    Yuen, C. T., Lawson, A. M., Chai, W. G., Larkin, M., Stoll, M. S., Stuart, A. C., Sullivan, F. X., Ahern, T. J. & Feizi, T. (1992): Novel sulfated ligands for the cell adhesion molecule E-selectin revealed by the neoglycolipid technology among O-linked oligosaccharides on an ovarian cystadenoma glycoprotein. Biochemistry 31, 9126–9131.PubMedCrossRefGoogle Scholar
  389. 390.
    Zollner, O. & Vestweber, D. (1996): The E-selectin ligand-1 is selectively activated in Chinese hamster ovary cells by the alpha(1,3)-fucosyltransferases IV and VII. J. Biol. Chem. 271, 33002–33008.PubMedCrossRefGoogle Scholar
  390. 391.
    Zopf, D. A., Ginsburg, A. & Glnsburg, V. (1975): Goat antibody directed against a human Leb blood group hapten, lacto-N-difucohexaose I. J. Immunol. 115, 1525–1529.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 2000

Authors and Affiliations

  • Helmut Schenkel-Brunner
    • 1
  1. 1.Institut für Medizinische BiochemieUniversität WienViennaAustria

Personalised recommendations